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Chemiluminescence is the light emission from a chemical reaction. The excited state is
accessed in the course of a chemical reaction and relaxes to the ground state with the emission of
a photon. Independence from the need for light excitation gives chemiluminescence several
advantages over fluorescence including better signal-to-noise ratio and reduced background at
deeper tissue imaging depth. As a result, the sensitivity of chemiluminescent probes for biological
analyte detection has been improved significantly. Because of the sensitivity of chemiluminescent
probes, we are planning to use this technique to quantify important factors for biological activities.
In this dissertation, two quantification methods to study biological activities will be
introduced in detail. The first one is a pH quantification system based on a pH sensitive
chemiluminescent system. In aqueous solution, the light emission from the chemiluminescent
probe will transfer to a ratiometric pH sensitive dye caboxy-SNARF-1 in the presence of a
commercially available enhancer. By plotting out the light emission ratio of the dual emission
peaks of carboxy-SNARF-1 with various pH, we can use this system as an optical pH detection
method.
The second project in this dissertation is the development of a chemiluminescent HNO
probe. Pharmacological HNO is related to a wide range of biological activities, but its detection is
difficult because of its instability and activity towards biological molecules. Based on a 1,2spirodioxetane structure, with the acrylonitrile on the orthro position of the phenolate, we
synthesized the first HNO chemiluminescent probe, HNOCL-1. The chemiluminescent intensity
of the scaffold has been improved significantly and is capable of HNO detection in the nanomolar
scale. With HNOCL-1, we successfully detected and quantified the HNO generated from the
reaction between NO and H2S, which is one of the possible endogenous sources of HNO.
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Chapter 1 Introduction to Chemiluminescence
1.1 Chemiluminescence

Internal Conversion
Intersystem Crossing

S1

T1

Fluorescence
Energy
Excitation

Phosphorescence
hv
hv

S0
Scheme 1 - 1. Jablonski Diagram for Chemiluminescence Mechanism.
From the fireflies in the woods, luminescent bacteria in the lakes, and jellyfish deep under
the sea, the splendid light emission of light is a beautiful part of the natural world. Back to the city,
people use glow sticks for parties, concerts and celebrations for festivals. Detectives and police
used luminol to track the hint of wiped blood. This chemical based light emission, which is called
chemiluminescence, is almost everywhere is people’s life. It is the remarkable production of light
from exothermic chemical reactions that can be understood using a Jablonski diagram describing
the interactions between light and molecules. The ground state electron in S0 will transit to the
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excited state S1 upon obtaining a sufficient amount of energy, which could come from the light
absorbance or a chemical reaction. For chemiluminescence, the energy is obtained from the
chemical reaction. Internal conversion happens when the electron relaxes to a lower energy state
without photon emission. The relaxation of the electron to the ground state with the release of a
photon will cause the light emission (Scheme 1-1). For fluorescence, the energy to excite the
electron is from external light. Intersystem crossing can also happen in this process, which is the
electron transition to the triplet excited state T1 before relaxation to the ground state with a slower
transition rate in a process called phosphorescence.1 Compared with fluorescence, light emission
from chemiluminescence does not rely on external light sources, which significantly increases the
tissue depth that can be adequately imaged when applied in a biological system. Meanwhile,
chemiluminescence will give a lower background in biological system due to reduced
autofluorescence and light scattering. Hence chemiluminescence is very useful for analytical
chemistry and has been used in a wide range of applications.
The application of chemiluminescence as an analytical method has been studied for a long
time since the concentration for most endogenous compounds have a low concentration and are
hard to detect.1 Before chemiluminescence methods, radiolabeling detection was a leading way to
trace analytes in biological systems, but has several drawbacks.2 Chemiluminescence provides a
less complicated and cheaper way compared to radiolabeling procedures. Studies on luminol,4
acridinium,5-6 peroxyoxalate,7 luciferin and luciferase8 and sterically stabilized 1,2-dioxetanes1 are
the most commonly reported systems.
1.2 Introduction of chemiluminescent systems
1.2.1 Luminol and its derivatives
O

O
NH -N2

NH
NH
NH 2 O

OH

NH 2 O

NH
OOH

*

OH

O
O
NH 2 O

O
O

+

Light

NH 2 O

Scheme 1 - 2. Chemiluminescence of luminol.
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The principle of light emission is the oxidation of the heterocyclic ring by a series of
oxidants to yield an important intermediate α-hydroxyperoxide, which decomposes to yield the
excited aminophthalate ion which relaxes back to the ground state and emits light.4 The oxidization
of luminol in protic solution needs oxidants that can include molecular oxygen, peroxides or
superoxide anion, but this reaction requires the presence of catalysis such as enzyme and medals
complexes.5

1.2.2 Acridinium and its derivatives
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X

CH 3
N
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+
CO2
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*

CH 3
N

O

O
O
+
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Scheme 1 - 3. Chemiluminescence of acridinium.
The basic chemiluminescence mechanism for acridinium and its derivatives is shown in
Scheme 1-3. With the hydroperoxide and a strong base, the acridinium will decompose and release
the acridone in its excited state, which will release a bright blue emission when it relaxes to the
ground state.6-7 It has been used as a efficient tool to label DNA strands without reacting with
thiols and sulfites.1
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1.2.3 Peroxyoxalate and its derivatives
Cl O
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Fluorophore *
+
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Light + Fluorophore

Scheme 1 - 4. Chemiluminescence of peroxyoxalic ester.
Peroxyoxalate and its derivatives have an aryl oxalate ester structure, which can react with
hydrogen peroxide to form the dioxetanedione with high energy. The dioxetanedione can
chemically excite the fluorophore to the S1 state and trigger the luminescence process.8 However,
the low stability and solubility in water limit the application of peroxyoxalic compounds in
biological systems.9
1.2.4 Luciferin and luciferase
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+
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Scheme 1 - 5. Chemiluminescence of luciferin with luciferase.
The basic light emission mechanism for luciferin and luciferase chemiluminescent system
is shown in Scheme 1-5. In the presence of ATP, O2 and Mg2+, luciferin will be catalyzed by
luciferase and turn into an intermediate with the 1,2-dioxetane, which will decompose into the
oxyluciferin in its excited state and release visible light when it relaxes into ground state.10 The
luciferase and luciferin bioluminescent system has a broad range of application. With various
luciferases, the light emission could change from 480 nm to 612 nm. It has been used to detect a
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series of biological activities including viral infection, host response, antiviral therapy and real
time monitoring and quantification of small molecule analytes.11
1.2.5 1,2-dioxetane
O O

O

O O

O

+

O

* T1

O

* S1

O O

+

Scheme 1 - 6. Chemiluminescence of 1,2-dioxetane.
The chemiluminescence mechanism of 1,2-dioxetane is shown is Scheme 1-6. There are
two distinct pathways for its decomposition, thermal and chemical decomposition. The thermal
decomposition of the 1,2-dioxetane will lead to the formation of the diradical intermediate and
release the decomposition product ketone in its triplet state (T1), which will be rapidly quenched
in aqueous solution. The chemical decomposition pathway will go through the chemically initiated
electron exchange luminescence (CIEEL) process, and lead to the generation of a ketone in its
singlet state (S1), which will emit light upon relaxing to the ground state. The generation of the
singlet intermediate makes the chemical decomposition for 1,2-dioxetane more efficient in
aqueous solution, and as a result, it will be a useful scaffold as tool to detect biological activities.1
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1.3 Development and Application of 1,2-spirodioxetane
1.3.1 Development of 1,2-spirodioxetane
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ONa
O

PG
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Scheme 1 - 7. Development of 1,2-dioxetane as a chemiluminescent probe.
Hundreds of molecules have been synthesized based on the 1,2-dioxetane structure.1 When
the 1,2-dioxetane moiety was first synthesized in 1969 (Scheme 1-7), it had several drawbacks
including thermal instability and aqueous quenching.1 In 1972, more stable structures of 1,2dioxetane with a 1,1′-biadamantyl group as stabilizer were developed, which have a higher
decomposition temperature and a longer half-life.12 The asymmetric structure of 1,2-dioxetane was
synthesized later. The chemiluminescence process would be triggered once the analyte-responsive
protecting group is removed.13-14 Schaap and his group developed several structures with a
silylated or ester group as protecting groups, which could react with fluoride anions or arylesterase
and initiate chemiluminescent processes in organic solvents (Scheme 1-7).15-17 Later, Bronstein
and colleagues developed (3-(2,7-spiroadamantane)-4-methoxy-4-(3-phosphoryloxy)phenyl-1,2dioxetane disodium salt also named 3-4-methoxyspiro(1,2-dioxetane-3,27-tricyclo[3.3.1.1.3,7]decan)-4-yl phenylphosphate disodium salt (AMPPD), the solubility in water and comparatively
stability at room temperature make it one of the most common structure for chemiluminescent
probes.13 Recently Shabat’s group develop several powerful chemiluminescent probes. By
attaching the acrylate or acrylonitrile electron-withdrawing group to the benzyl moiety, the
quantum yield and chemiluminescent intensity are increased dramatically.18
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1.3.2 Chemically initiated electron exchange luminescence
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Scheme 1 - 8. Chemical initiated electron exchange luminescence.16
CIEEL is light emission from electron-transfer chemistry, which is part of the
chemiluminescent process. Intermolecular electron transfer or intramolecular electron transfer of
thermostabilized spiroadamantyl-substituted dioxetanes is the main reason for CIEEL. When the
protecting group is removed from the scaffold, it will release the phenolate anion, which would
lead to the decomposition of spiroadamantyl-substituted dioxetane and initiate the light emission.
Two alternative decomposition mechanisms have been proposed for CIEEL process. The cleavage
of the phenolate anion will lead to the intramolecular electron transfer (ET) from the phenolate
moiety to the antibonding s* orbital with the cleavage of O-O bond.19 This is the rate-limiting step
for CIEEL since it need energy for the electron transfer from the phenolate to the peroxide bond.
The excited methyl m-oxybenzoate ion could be formed from the direct electron transfer, but the
research evidence support the alternative way, which is the electron back transfer (BET). BET
happens in the slovent cage between the radical fragments from the decomposition of
spiroadamantyl-substituted dioxetanes phenolate, which has been demonstrated by the solvent
viscosity dependence of the chemiexcitation yield of the system. This phenomenon has been
demonstrated that the chemiexcitation yield is rising with the increasing viscosity.20 Finally, the
excited methyl m-oxybenzoate ion relaxes to the ground state and leads to the light emission.
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1.3.3 Probes based on 1,2-spirodioxetane in aqueous solution
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Scheme 1 - 9. Probes based on 1,2-spirodioxetane scaffold.
A range of probes based on the 1,2-spirodioxetane scaffold for reactive oxygen and
nitrogen species and reactive biological analyte detection has been synthesized recently in our lab
(Scheme 1-9). CHS-1-3 are the first generation of these probes. The benzyl azide will react with
H2S and yield an aniline, which will lead to the generation of the phenolate ion and CIEEL.
Although among these probes, CHS-3 gives the strongest light emission, it still relies on the
addition of a commercially available enhancer, Emerald II to increase light emission.21 Later, the
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chlorinated 1,2-dioxetane Hycl-2 was synthesized as a tool to detect hypoxia. The nitrobenzene
will be reduced to aniline under hypoxic conditions by mammalian reductive enzymes and release
the phenolate ion to initiate the CIEEL process. This scaffold still relies on the addition of
enhancers to magnify the emission intensity.22 A pH quantification system with the addition of the
enhancer was developed later after Hycl-2.23 With the attachment of an acrylate or acrylonitrile
electron-withdrawing group to the aromatic moiety, the chemiluminescence emission intensity of
the 1,2-spirodioxetane has been significantly improved because the quantum yield of the
fluorophore released from the decomposition of the dioxetane has increased.18 As a result, probes
based on the acrylate and acrylonitrile dioxetane do not require the addition of enhancers for
reactive oxygen and nitrogen species detection. PNCL and HNOCL-1 were synthesized later to
detect ONOO– and HNO respectively and gave a high sensitivity towards the analytes.24-25
Recently, our group found with the addition of the acetoxymethyl ester to the benzoic moiety could
increase the cell trappability of the 1,2-dioxetane. Upon reaction with intercellular esterases when
treating the cells with the probe, the acrylate carboxylic acid intermediate will be released from
the system and increase the solubility of the scaffold. As a result, light emission will be improved
significantly. Based on this structure, our group developed the second-generation probes for
hypoxia detection Hycl-3 and Hycl-4-AM that gave us a much brighter response towards hypoxia
upon adding to the cells compared with other probes.26

1.4 Research objectives
This dissertation aims to quantify factors that are related to certain biological activities. The aim
for the pH quantification project is using a chemiluminescent probe as the light source to transfer
light emission to a ratiometric pH sensitive fluorophore carboxy-SNARF-1. By establishing a
standard graph of the relationship between pH and light emission ratio, it can be used to detect the
pH using an optical method.27 The HNO quantification project aims to development a highly
selective and sensitive chemiluminescent probe HNOCL-1 to detect HNO at nanomolar
concentrations. The HNO detection and quantification has been successfully conducted in vitro to
provide a quantification of HNO generated. Hence, HNOCL-1 could provide an efficient way to
study the pathways and functions of HNO in biological systems in the future.
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Chapter 2 Detection of pH with a chemiluminescent probe
2.1 Introduction
2.1.1 Misregulated pH in cancer cells
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Figure 2- 1. Misregulated pH in cancer and normal cells.
Regulated pH is an important factor to keep the balance of the human body. Normal cells
have a lower intracellular pH (pHi) of 7.2 compared to the extracellular pH (pHe) of 7.4, which is
buffered by HCO3– (Figure 2-1).1 This characteristic is important for normal adult cell metabolism
and apoptosis.2 Cancer cells have a higher intracellular pH and lower extracellular pH compared
to normal adult cells. The increased production of lactic acid and the change of the expression of
the cell membrane transporters and pumps lead to this abnormal pH condition of cancer cells.3 The
fast proliferation rate of cancer cells means that the normal cellular metabolism in healthy adult
cells cannot meet the requirement for energy.4 As a result, cancer cells resort to another way of
energy production, which involves the breakdown of glucose in cytosol with the generation of
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lactic acid.4 Meanwhile, a change in the expression of ion pumps and transporters on the cell
membrane speeds up the H+ efflux and leads to the increase of extracellular H+ concentration.5

2.1.2 High intracellular pH increases proliferation
The higher intracellular pH (pHi > 7.2) is a key factor for cancer cell proliferation due to
the inhibition of cell acidification controlled apoptosis.6 The function of cyclin-dependent kinase
1 (CDK1), the key complex for promoting mitosis, is limited under lower pHi.7 However, a higher
intracellular pH facilitates the CDK1 activities and promotes G2/M process entry and cell mitosis.7
Also, pH dynamics can change the activity of certain proteins and inhibit several processes of cell
apoptosis.8 In acidic cytosol, a pre-apoptosis protein induces pore formation on the mitochondria
membrane and releases another pre-apoptosis protein cytochrome c, which is important to facilitate
the activity of caspases and at pH 6.8, efficiency of these caspases reaches maximum.8 With a
higher pHi the function of cytochrome c will be suppressed and the cell death process will be
inhibited.9 Moreover, the function of lactate dehydrogenase, a key enzyme for pyruvate conversion
of lactate, is maximal at pH 7.5. Furthermore, the activity of the most important glycolysis rate
regulated enzyme phosphofructokinase 1 is increased with an alkaline pH shift.10

2.1.3 Low extracellular pH increases invasion and metastasis
Meanwhile, a lower pHe is the main reason for extracellular matrix (ECM) remodeling and
acid-activated protease activities enhance and promote tumor cell invasion and metastasis.11 An
ECM degradation enzyme, matrix metalloproteinase 3 is more active at lower pHe.12 However, the
reason for the dysfunction is not well understood. Hence, it’s important to monitor the real time
pH dynamics to facilitate studying and understanding the mechanisms behind these organs'
misbehaviors.
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2.1.4 pH measurement by magnetic resonance
Magnetic resonance is a key technique for measuring pH in tumors and measurement
methods include 31P MRS,13 19F MRS,14 13C MRS,15 magnetization transfer16 and pH-dependent
chemical reagents.17 Some of these methods are aimed at testing the endogenous resonance while
31

other require exogenous reagent injection.

P MRS is used to detect the resonance of endogenous

phosphate Pi, but for necrosis cells, the extracellular Pi is also visible on the spectra, which can
cause the appearance of complicated resonances. Another method is to measure the extracellular
pH by injecting 3-aminopropylphosphate (3-APP), which is membrane impermeable and nontoxic, and measures the pH-dependent shift of 31P.15 Another pH measurement by MRS is 19F MRS,
which has a high gyromagnetic ratio and is not be influenced by endogenous sources of 19F, which
are very low in tissue. By injecting exogenous reagents, it is possible to obtain the spectra with
large chemical shift dispersion. 1H MRS can also provide highly sensitive spectra with a stable,
downfield region with slight interferences.18 Even though some endogenous molecules can also
have H-resonance responses, these compounds are too dilute to be observed from the spectra.
Hyperpolarized 13C MRS is also an innovative method to detect the intercellular pH by intravenous
injection of hyperpolarized bicarbonate H13CO3–.17
2.1.5 Ratiometric pH sensitive fluorescent probe: carboxy-SNARF-1
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Scheme 2 - 1. Structure and dual emission of carboxy-SNARF-1 at different pH.21
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Numerous pH sensitive fluorescent probes have been synthesized and reviewed.19-20 The
light emission of these probes will shift with the change of pH. It is because of protonation or
deprotonation of a certain function group.19-20 Carboxy-SNARF-1 is a commonly used ratiometric
dye that has a clear isosbestic point at around 600 nm. Its pKa is around 7.4, which is appropriate
as a pH detector. The single excitation and dual emission of carboxy-SNARF-1 make it a
convenient dye for pH detection in various instruments.21,23
2.1.6 pH measurement by optical methods
Optical pH measurement is another commonly used strategy to detect pH. With the
existence of a ratiometric pH sensitive fluorescent dye – carboxy-SNARF-1 and cell membrane
permeable fluorescein, the pH of mitochondria has been detected by high resolution confocal
scanning laser microscopy (CSLM) and multiphoton laser scanning microscopy (MPLSM).22
CSLM is able to detect emission signals at different wavelengths at the same time. This property
enables the detection of the two emission peaks of carboxy-SNARF-1 in various pH
microenvironments.23 Another pH detection method is using pH (Low) Insertion peptide–pHLIP.24
The peptide is a water-soluble polypeptide and would form a transmembrane alpha helix with the
drop of intercellular pH from 7.4 to around 6.5–7.0. By this way, cargo molecules can attach to
the cell membrane surface or the membrane-impermeable molecules and will enter into the cell
plasma.24

2.1.7 Enhancers
The CIEEL is generated with the decomposition of the deprotonated 1,2-spirodioxetane
phenolate ion. The decomposition rate of phenolate ion is 4.4 x 106 faster than the protonated
phenol.25 The fluorophore released from decomposition of the probe is in a charge transfer state,
which can be quenched by proton transfer in the protic solution. Fortunately, the quenching process
can be prevented by the hydrophobic microenvironment formed by the surfactant from the
enhancer. With the addition of the enhancer, the chemiluminescence emission intensity will be
improved significantly.26 Meanwhile, the micelle formed from the added surfactant would attach
the fluorophores to the system and increase the energy transfer efficiency.27 In our lab, we used
the commercially available enhancers Emerald II and Sapphire II to improve the chemiluminescent
emission intensity. There is also a fluorophore in the enhancers that can be excited by the CIEEL
and lead to the red-shift of the emission. Poly (vinylbenzyltrimethylammoniumchloride) (TMQ),
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poly

(vinylbenzyltributylammoniumchloride)

(TBQ)

and

poly

(vinylbenzyldimethylbenzylammonium chloride) (BDMQ) are the surfactants include in the
enhancers. By surrounding the 1,2-dioxatane structure into the hydrophobic microenvironment,
they keep the protonation of the 1,2-dioxetane and enhance the chemiluminescence of the probe.
2.2 Results and discussion
2.2.1 Design and synthesis of pH sensitive probe and ratiometric pH sensitive fluorophore
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Scheme 2 - 2. Synthesis procedures of 1.
The synthesis procedure of the 1,2-dioxetane probe is adopted from previous work in our
laboratory.28 First, we treated the 4-chloro-3-methoxylbenzaldehyde 2 with trimethyl orthoformate
in MeOH in the presence of p-toluenesulfonic acid to yield acetal 3. The acetal 3 was treated with
triethyl phosphite and boron trifluoride diethyl etherate to obtain the diethyl methoxy (3methoxyphenyl) methyl phosphonate 4. We ran the Horner–Wadsworth–Emmons reaction with
the phosphonate 4, n-BuLi and 2-admantanone to yield the enol ether 5. Next, the enol ether 5
would go through a demethylation reaction upon treatment with sodium ethanethiolate and cesium
carbonate to obtain the phenol 6. Later, I protected the phenol with a MOM protecting group
through the addition of chloromethoxymethane29 to yield the MOM protected enol ether 8. The
MOM protected enol ether underwent reaction with Rose bengal as the catalyst and O2 bubbled
through the system, and this procedure obtained the 1,2-dioxetane structure MOM protected
product 8. The MOM protecting group was removed by adding p-toluenesulfonic acid to yield the
pH sensitive probe Compound-1.
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2.2.2 Synthesis and isolation of carboxy-SNARF-1
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Scheme 2 - 3. Synthesis procedures of carboxy-SNARF-1.
The synthesis of carboxyl-SNARF-1 was adapted from the procedure published by Dr.
Christopher J. Chang in 2011.30 1,3-Dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid mixed
with 3-dimethylaminophenol was heated up to 110°C and stirred overnight in toluene to yield the
product 9. The product 9 was mixed with 1,6-naphthalenediol in pure MeSO3H and stirred for 1
hour and obtain the product 10 as a purple solid.30
2.2.3 Mechanisms of pH quantification
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Scheme 2 - 4. Energy transfer chemiluminescence for ratiometric pH imaging.31
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To obtain the pH sensitivity properties of 1 and the ratiometric pH sensitive dye carboxySNARF-1, we first characterized the chemiluminescence result using a F-7000 Hitachi
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fluorometer. Luminescence response toward the change of pH was tested in PBS (0.02 M, pH 6.0–
8.0) buffer and sodium bicarbonate (0.01 M, pH 9.2–10.8) buffer solution. We developed the
system with two different commercially available enhancers Emerald II and Sapphire II. With a
tetra-alkyl ammonium polymer in the Sapphire II (6%) that encapsulates the dioxetane 1 and the
carboxy-SNARF-1, the energy transfer efficiency has been significantly improved. There are two
main emission peaks in the Sapphire II enhancer solution. The one at 467 nm is the light emission
from the decomposition of 1 and the rising peak at 650 nm with the increasing pH is from the
deprotonated carboxy-SNARF-1. We plotted out the ratio of light emission respectively at 650
nm and 585 nm, which are the two emission peaks for protonated and deprotonated carboxySNARF-1, and a pH dependent graph was constructed. The emission peak at 585 nm is masked
by the peak at 467 nm, but this is still the peak at which the maximum change is observed. From
this graph, we can see a 5.6-fold increase in the ratio with increasing pH from 5.99 to 10.02 (Figure
2-2, A-B), which confirms that the system we have established has the ability to quantify the pH
in an aqueous system. We observed similar results with another commercially available enhancer
Emerald II. In the 6% Emerald II buffer solution, there are 3 emission peaks at 467 nm, 540 nm
and 650 nm, which are respectively from the light emission of dioxetane 1, the fluorophore
included in the enhancer and the deprotonated carboxy-SNARF-1. After plotting out the ratio of
chemiluminescence at 650 nm and 585 nm, we can see a 5.7-fold increase in the ratio with the
increasing pH from 5.99 to 10.02 in the graph (Figure 2-2, C-D).
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Time is another important factor that could lead to the change of the chemiluminescent
emission intensity since a decrease of chemiluminescent emission has been observed over time in
solutions of dioxetane 1 in aqueous buffer solution with time scan mode. To test if time can cause
any effect to the results, we did a wavelength scan of each sample every 5 mins for 30 mins. We
plot out the result of the ratio of 650 nm emission to 585 nm. In the Sapphire II enhancer solution,
we can see a significant decrease of chemiluminescent emission over time, but when we plot out
the ratio, it stays constant. Similar results have been oberserved in an Emerald II enhacner solution.
We also conducted this test with different pH buffers, and no matter how the time changes, the
ratio stays the same. In this way, the time independence of this pH quantification system has been
demonstrated.
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or (B) 640 nm ﬁlter in an IVIS Spectrum.

ular Chemistry

for this approach. FBS (fetal bovine serum) is the main nutrition for the cell in mammalian cell
maintenance, and it contains a variety of proteins. We can imitate the biological system by adding
FBS to the PBS buffer and test our system in this solution. Constant pH with the addition of 10%
FBS to the PBS buffer has been confirmed with a pH meter. We tested our system with Emerald
II enhancer. The results show that the addition of FBS doesn’t cause any change to the ratio of
CL650nm/CL585nm in our system, which demonstrates that we can used this system in a more
complicated biological system.
View Article Online

2.2.7 In vitro testing under IVIS spectrum
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tration of the dioxetane. The system also provides an accurate
measurement of pH in the presence of fetal bovine serum, methylene)adamantine (3). DIPEA (1.00

7.2, 7.4, 7.6, 7.8, or 8.0 in PBS buffer with 6 % Sapphire II enhancer, 30 μM dioxetane 1 and 40
μM carboxy-SNARF-1. The IVIS Spectrum could capture the picture of light emission at 580 nm
and 640 nm. In the Sapphrie II enhancer solution, the light emission intensity at 580 nm is much
lower than 640 nm (Figure 2-6, A-B). Each pH has 6 replicates in this test. The computer program
can calculate the sum of light emission from each well, and by plotting out the ratio of
CL640nm/CL580nm, a graph has been obtained and a 4-fold increase of CL640nm/CL580nm ratio from
pH 6-8 has been observed (Figure 2-8, A). Similar results have been observed with Emerald II as
the enhancer (Figure 2-7, A-B) and according to the graph (Figure 2-8, B), a 3-fold increase of
CL640nm/CL580nm ratio from pH 6-8 is obtained.
2.3 Conclusions
Herein, we have realized quantitative ratiometric chemiluminescence imaging of pH via
the transfer of energy from a chemiluminescent excited state of a phenolate derived from the
decomposition of 1 to the ratiometric pH sensitive dye carboxy-SNARF-1. The synthesis and
isolation of 1 was of key importance in providing a bright chemiluminescent system to ensure
excitation of carboxy-SNARF-1. The system provides a reliable ratiometric response to variable
pH, which is independent of confounding variables such as time and the concentration of the
chemiluminescent probe. The system also provides an accurate measurement of pH in the presence
of fetal bovine serum, demonstrating operational compatibility with complex biological fluids.
Protocols have been established for the quantification of pH using chemiluminescence imaging on
an IVIS Spectrum. Due to increased luminescence emission in the range between 585 nm and 650
nm, the system containing the Emerald II Enhancer provides greater signal-to-noise for pH
measurement. On the other hand, the system containing the Sapphire II Enhancer provides a higher
magnitude change in the ratiometric signal. Some fluctuations are seen when the volumes of the
Enhancer solutions are altered, a problem that is more severe in the case of the Emerald II Enhancer.
The formulation of systems with stable polymeric encapsulation or covalent linkage of
components to ensure consistent stoichiometry could provide solutions to this issue. Nevertheless,
quantitative imaging of pH using this ratiometric chemiluminescent system has been achieved. We
ultimately anticipate that similar strategies will be compatible with the current library of known
ratiometric fluorescent probes to provide a powerful new toolkit for ratiometric
chemiluminescence imaging.
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2.4 Synthesis Procedures
2.4.1 General materials and methods
All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel P60
(SiliCycle) was used for column chromatography and SiliCycle 60 F254 silica gel (precoated
sheets, 0.25 mm thick) was used for analytical thin layer chromatography. Plates were visualized
by fluorescence quenching under UV light or by staining with iodine. Other reagents were
purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward Hill, MA), EMD Millipore
(Billerica, MA), Oakwood Chemical (West Columbia, SC), and Cayman Chemical (Ann Arbor,
MI) and used without further purification. 1H NMR and 13C NMR spectra for characterization of
new compounds and monitoring reactions were collected in CDCl3 (Cambridge Isotope
Laboratories, Cambridge, MA) on a JEOL 500 MHz spectrometer in the Department of Chemistry
at Southern Methodist University. All chemical shifts are reported in the standard notation of parts
per million using the peak of residual proton signals of the deuterated solvent as an internal
reference. Coupling constant units are in Hertz (Hz) Splitting patterns are indicated as follows: br,
broad; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublets; dt, doublet
of triplets. High resolution mass spectroscopy was performed on a Shimadzu IT-TOF (ESI source)
and low resolution mass spectroscopy was performed on a Shimadzu LCMS-8050 Triple
Quadrupole LCMS (ESI source) or a Shimadzu Matrix Assisted Laser Desorption/Ionization MS
(MALDI) at the Shimadzu Center for Advanced Analytical Chemistry at the University of Texas,
Arlington.

O
PO(OEt) 2
Cl
O

4

Diethyl((4-chloro-3-methoxyphenyl)(methoxy)methyl)phosphonate

(4).

4-Chloro-3-

methoxybenzaldehyde (1502 mg, 8.8 mmol, 1 equiv) was dissolved with 5 mL MeOH in a dry
flask filled with N2. Trimethyl orthoformate (0.96 mL, 9.3 mmol, 1.1 equiv) and p-Toluenesulfonic
acid (147 mg, 0.9 mmol, 0.1 equiv) was added to the flask. The mixture was stirred for 24 hours
at room temperature under N2. After that the mixture was neutralized by NEt3. Pour 30 mL

50

NaHCO3 to the mixture and extract with 3 x 30 mL EtOAc. The organic layer was dried by Na2SO4,
filtered and concentrated under reduced pressure to obtain crude acetal 3(1897.4 mg). Compound
3 was dissolved in 5 mL DCM at 0°C. Triethyl phosphite (1.65 mL, 10.2 mmol, 1.2 equiv) and
boron trifluoride etherate (1.13 mL, 9.00 mmol, 1.0 equiv) were added to the flask at 0°C. The
reaction was raised to 30°C and stirred for 1 hour. The reaction was quenched by 30 mL NaHCO3,
extracted by 3 x 30 mL EtOAc and dried by Na2SO4 and filtered. Evaporate the EtOAc under
reduced pressure and purify by column chromatography (1:15 EtOAc/Hexane) yield the product
as a pale yellow oil (13389 mg, 47%). 1H NMR (500 MHz, CDCl3) d 7.23 (d, 1H, J = 8.1 Hz),
6.98 (t, 1H, J = 2.0 Hz), 6.83 (dt, 1H, J = 6.3, 2.0 Hz), 4.37 (d, 1H, J = 16.1 Hz), 3.86–4.00 (m,
4H), 3.81 (s, 3H), 3.29 (s, 3H), 1.11–1.26 (m, 6H); 13C NMR (125 MHz, CDCl3) d 154.82, 134.40,
129.72, 122.29, 120.74, 111.12, 80.44, 79.43, 63.05 (d, J = 10.7 Hz), 62.81 (d, J = 10.7 Hz), 58.65
(d, J = 14.3 Hz), 55.97, 16.26 (d, J = 5.9 Hz), 16.18 (d, J = 5.9 Hz); HRMS calcd for C13H20ClO5P
(M+Na+) 345.0629, found 345.0624.
O
O
Cl
5

(1r,3r,5R,7S)-2-((4-chloro-3-methoxyphenyl)(methoxy)methylene)adamantine
(5). Compound 4 (1339 mg, 4.2 mmol, 1.0 equiv) was dissolved in 5 mL anhydrous THF in a dry
flask under N2 and cooled to –78 °C by adding dry ice to acetone. 2-Adamantanone (786 mg, 5.2
mmol, 1.2 equiv) was dissolved in 5 mL anhydrous THF and cooled to –78 °C by the same way.
Add 5 mL 1.6 M n-BuLi to the compound 4 solvent at –78 °C and stirred for 6 min. Add the cooled
2-adamantanone solvent to the flask and raise the temperature of the reactant to 30 °C. The mixture
was stirred for 2 hours and the temperature was raised to 90 °C under reflux. After 1 hour reflux,
the reaction was quenched by 30 mL NH4Cl and extracted by 3 x 30 mL EtOAc. Purification by
chromatography (1:15 EtOAc/Hexane) yield Compound 5 as colorless oil (1351 mg, >95%). 1H
NMR (500 MHz, CDCl3) d 7.30 (d, 1H, J = 8.0 Hz), 6.91 (d, 1H, J = 1.8 Hz), 6.83 (dd, 1H, J =
8.0, 1.8 Hz), 3.89 (s, 3H), 3.30 (s, 3H), 3.24 (s, 1H), 2.62 (s, 1H), 1.58–1.97 (m, 12H); 13C NMR
(125 MHz, CDCl3) d 154.84, 142.77, 135.44, 132.56, 129.62, 122.54, 121.41, 112.82, 57.90, 56.16,
39.24, 39.11, 37.21, 32.43, 30.35, 28.34; HRMS calcd for C19H23ClO2 (M+H+) 319.1459, found
319.1461.
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O
OH
Cl
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5-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chlorophenol (6). Compound 5
(1351 mg, 4.2 mmol, 1.0 equiv) was dissolved in 14.4 mL anhydrous DMF at room temperature
in a dry flask under N2. Cs2CO3 (3436 mg, 10.5 mmol, 2.5 equiv) and EtSNa (867 mg, 10.3 mmol,
2.5 equiv) was added to the flask. The temperature of the mixture was raised to 90 °C under reflux
for 16 hours. The reaction was quenched by 30 mL of NH4Cl, extracted by 3 x 30 mL, dried over
Na2SO4 and evaporated under reduced pressure. Purification by column chromatography (1:15
EtOAc:Hexane) yield compound 6 as a white solid (954 mg, 74%). 1H NMR (500 MHz, CDCl3)
d 7.28 (d, 1H, J = 8.0 Hz), 6.98 (d, 1H, J = 3.5 Hz), 6.83 (dd, 1H, J = 8.0, 3.5 Hz) 5.95 (s, 1H),
3.30 (s, 3H), 3.22 (s, 1H), 2.62 (s, 1H), 1.55–1.96 (m, 12H); 13C NMR (125 MHz, CDCl3) d 151.12,
142.18, 135.88, 132.79, 128.57, 122.38, 118.84, 116.97, 57.80, 39.08, 38.94, 37.04, 32.22, 30.21,
28.17; HRMS calcd for C18H21ClO2 (M–H+) 303.1157, found 303.1150.
O
O

O

Cl
7

(1r,3r,5R,7S)-2-((4-chloro-3-methoxymethylphenyl)(methoxy)methylene)adamantine (7).
DIPEA (1.00 mL, 5.7 mmol, 1.8 equiv) was added to a solution of compound 6 (954 mg, 3.1 mmol,
1.0 equiv) in 10 mL DCM at room temperature under N2. Chloromethoxymethane (0.47 mL, 6.2
mmol, 2.0 equiv) was added dropwise to the solvent at 0 °C. After the addition of
chloromethoxymethane, the reaction was raised to room temperature and stirred for 2.5 hours.
Quench the reaction with 30 mL saturated aq NH4Cl and the mixture was extracted with 3 x 30
mL DCM and evaporated under reduced pressure. Purification by chromatography (1:12
EtOAc/Hexane) yielded compound 7 as a colorless oil (662 mg, 61%). 1H NMR (500 MHz, CDCl3)
d 7.30 (d, 1H, J=10.0 Hz), 7.12 (s, 1H), 6.90 (dd, 1H, J=10 Hz), 5.21 (s, 2H), 3.55 (s, 3H), 3.28 (s,
3H), 3.22 (s, 1H), 2.62 (s, 1H), 1.69-1.95 (m, 12H); 13C NMR (125 MHz, CDCl3) d 151.48, 135.64,
129.02, 121.20, 111.53, 95.57, 50.02, 47.10, 39.38, 36.43, 34.82, 33.21, 32.34, 31.75, 31.61, 31.04,
27.90, 26.07, 25.94. (M–H+), found 381.1463.
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OO

O

O

Cl
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Compound 7 (208 mg, 0.6 mmol, 1.0 equiv) and Rose Bengal (21.2 mg, 0.02 mmol, 0.03 equiv)
were added into a dry two-neck flask and dissolved in 5 mL THF. O2 was bubbled through the
solvent while illuminated with a 120W light bulb (Home Depot, Dallas, TX) at 0–5 °C. Monitor
the reaction by TLC. After 4 hours, the mixture was concentrated at 0 °C. Purification by silica
column chromatography (1:15 EtOAc/Hexane) delivered compound 8 as a yellow oil (206 mg,
91%). 1H NMR (500 MHz, CDCl3), d 7.01–7.64 (m, 3H, br), 5.28 (m, 2H), 3.49 (s, 3H), 3.20 (s,
3H), 3.01, (s, 1H), 2.12 (s, 1H), 1.45-1.90 (m, 12H); 13C NMR (125 MHz, CDCl3) d 152.62, 134.80,
130.13, 125.03, 111.61, 95.47, 56.30, 49.98, 39.50, 35.43, 33.24, 33.11, 31.71, 31,58, 30.30, 26.08,
26.00. MS not found.

O

OO

OH
Cl

Compound 1

Compound 8 (651 mg, 1.7 mmol, 1.0 equiv) was dissolved in 10 mL MeOH at room temperature.
p-toluenesulfonic acid (37.3 mg, 0.2 mmol, 0.1 equiv) was dissolved in 10 mL MeOH at room
temperature. The p-toluenesulfonic acid solvent was added to the compound 7 drop by drop. After
addition of p-toluenesulfonic acid, the mixture was raised to 65 °C and stirred for 6.5 hours. The
mixture was quenched by 50 mL brine and extracted by 3 x 50 mL EtOAc and evaporated under
reduced pressure. Purification was by silica column chromatography (1:20 EtOAc/Hexane).
Compound 1 was obtained as a white solid (303 mg, 53%). 1H NMR (500 MHz, CDCl3) d 7.02–
7.53 (m, 3H, br), 5.81 (s, 1H), 3.22 (s, 3H), 3.05 (s, 1H), 2.17 (s, 1H), 1.43–1.83 (m, 12H); 13C
NMR (125 MHz, CDCl3) d 151.42, 135.70, 121.20, 111.52, 95.71, 50.04, 47.05, 39.20, 36.44,
34.82, 33.21, 33.18, 32.50, 31.75, 31.61, 26.07, 25.94. (M–H+) found 349.1565.
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O

N

OH

O

OH

OH
O

9

4-[4-(dimethylamino)-2-hydroxybenzoyl]- 1,3-Benzenedicarboxylic acid (9).
1,2,4-Benzenetricarboxylic

anhydride

(2105

mg,

11.0

mmol,

1.0

equiv)

and

3-

(Dimethylamino)phenol (1505 mg, 11.0 mmol, 1.0 equiv) were added to a dry flask and dissolved
with 30.0 mL toluene. The mixture was raised to 120 °C and stirred overnight. The mixture was
washed by toluene 3 x 30 mL, 3 x 50 mL DCM and 3 x 50 mL EtOAc and filter the product and
vacuum dry. Purification was by silica gel column chromatography (1:18 MeOH:DCM).
Compound 9 was obtained as a dark green solid (3126 mg, 79%). 1H NMR (500 MHz, CDCl3) d
12.36 (s, 1H), 12.33 (s, 1H), 6.76–8.50 (m, 6H), 6.07 (s, 1H), 2.97 (d, 6H, J=2.5).
OH
N

O

O
O

O
H

O

Carboxy-SNARF-1

1,3-Benzenedicarboxylic acid, 4-[4-(dimethylamino)-2-hydroxybenzoyl] (2657 mg, 8.1 mmol,
1.0 equiv) and 1,6-naphthalenediol (1383 mg, 8.6 mmol, 1.1 equiv) were added to a dry, vacuum
and N2 filled flask. Later 5 mL of MeSO3H was added to the flask and stirred for 3 hrs. The mixture
was washed by water 3 x 30mL, EtOAc 3 x 30 mL and DCM 30 mL. Purification was by column
chromatography (1:4 MeOH:DCM) and yielded carboxy-SNARF-1 as a purple solid (340 mg,
9%). 1H NMR (500 MHz, CDCl3) d 10.35 (s, 1H), 10.21 (s, 1H), 6.56–8.42 (m, 11H), 6.96 (s, 1H),
3.32 (s, 6H).

2.4.2 Imaging experiments with Fluorescence Spectroscopy
Chemiluminescent responses were acquired with a Hitachi F-7000 Fluorescence
Spectrophotometer (Hitachi, Tokyo, Japan) using the luminescence detection mode. The
Spectrophotometer scan mode was set as wavelength scan with the range of emission wavelength
from 400 nm to 900 nm and scan speed was set to 1200 nm / min. Response time was set to 2.0 s.
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pH 5.5 was made from 0.2 M Citric Acid – Sodium Citrate Buffer Solutions while pH 6.0 – 8.0
was made from 0.2 M PBS buffer solution and pH 9.2 – 10 was made from 0.1 M Sodium
Carbonate – Sodium Bicarbonate Buffer Solutions.

2.4.3 pH dependence property
463 µL buffer, 30 µL of Emerald II enhancer or Sapphire II enhancer, 4 µL carboxySNARF-1 solvent (10mM) in DMSO and 3 µL 10mM Compound-1 in DMSO were added to a
quartz cuvette (Starna, Atascadero, CA). The cuvette was shaken gently to assure mixing. The
cuvette was placed in the middle of the Spectrophotometer and obtained the wavelength scan graph.
The procedure was repeated with all the buffers in different pH.

2.4.4 Time independence property
463 µL PBS buffer solution, 30 µL of Emerald II enhancer or Sapphire II enhancer, 4 µL
carboxy-SNARF-1 solvent (10mM) in DMSO and 3 µL Compound-1 solution (10mM) in
DMSO were added to a quartz cuvette (Starna, Atascadero, CA). The cuvette was shaken gently
to mixed. The cuvette was placed in the spectrophotometer and the wavelength scan mode was run
every 3 mins for ten times.

2.4.5 Probe independence property
465 µL 0.2 M pH 7.4 PBS buffer solution, 30 µL Emerald II enhancer or Sapphire II
enhancer, 4 µL carboxy-SNARF-1 solution (10 mM) in DMSO and 1 µL Compound-1 solution
(10 mM) in DMSO were added to a quartz cuvette (Starna, Atascadero, CA). The cuvette was
shaken gently to assure mixing. The cuvette was placed in the center of spectrophotometer and
obtained the wavelength scan graph and repeat the experiment with increasing amount of
Compound-1 solution from 1 µL to 10 µL (1 µL each time) and decreasing amount of buffer
solution from 465 µL to 456 µL (1 µL each time).
2.4.6 Imaging experiments with IVIS Spectrum
Chemiluminescent responses were acquired with an IVIS Spectrum (Caliper, Waltham, MA) using
the “Luminescent” and “Photograph” mode. The exposure time was set as 2 seconds, and the
binning was set to small. The F/stop was set to 4, and the FOV was set to C, which means the field
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of view was set to 13 cm. With these settings, images could be acquired with 267 μM spatial
resolution. The height of each photograph was 1.5 cm. The excitation was blocked and a sequence
was set for the emission mode. The sequence was set as 580 nm, 640 nm, 580 nm, 640 nm, 580
nm and 640 nm. 231.5 μL aliquots of PBS buffers with pH from 5.99–8.01 were added to the wells
on the 96-well plate from A1 to A8. Later 2 μL of a 5 mM stock solution of carboxy-SNARF-1
(80 μM final concentration) in DMSO was added to each well followed by the addition of 15 μL
Emerald II Enhancer or Sapphire II Enhancer. Next 1.5 μL of a 5 mM stock solution of 1 in DMSO
was added to each well after the adding of the buffer, enhancer and carboxy-SNARF-1. This was
repeated in groups A1 to A8 for 6 times on each plate. The sequence described above was acquired
and the images were analyzed using the Living Image software.
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Chapter 3 A Chemiluminescent Probe for HNO Quantification
and Real-time Monitoring in Living Cells
3.1 Introduction
3.1.1 What is HNO
Nitroxyl (HNO) is the reductive product of NO with the addition of one electron and one
proton. NO– is isoelectronic to molecular oxygen and has a triplet ground state, which raises the
pKa of HNO to 11.1 HNO will dimerize and eliminate water to rapidly form nitrous oxide (N2O)
(k = 8 x 106 M–1s–1 at 23 ºC).2 At pH > 11, the 3NO– will react with 3O2 and yielded ONOO–. 3,4
Thiols5 and iron in heme-containing proteins6 are two main biological targets for HNO.

3.1.2 Biological and pharmacological functions of HNO
NO has been recognized as a vasodilator and endothelium-derived relaxing factor (EDRF)
since the 1980s. NO can activate the heme protein soluble guanylyl cyclase (sGC) and can lead to
the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), a
key factor to initiate a cascade of biological activities that result in vasodilation.7 Studies have
been done with isolated sGC exposed to donors like HNO, NO and NO+, and the results showed
that the sGC will be activated only when exposed to NO.8 This result implies that the HNO induced
vasodilation is because of the oxidation of HNO to NO in tissue that leads to the generation of
cGMP and result in the sGC activating.9 A range of biological reagents could help HNO to convert
to NO including SOD, metHP and flavins.10 However only small portion (<5%) of HNO could be
converted to NO in biological conditions,10 which leads to the question that if HNO itself could
directly lead to the vessel relaxation. Recent evidence supports the possibility that HNO could
regulate vascular tone and blood flow through an HNO/TRPA1/CGRP pathway.11-12
Pharmacological HNO can be used as a pain reducer in animal models through a cGMP/PKG/KATP
pathway.13 Pharmacological HNO is being investigated as a treatment for heart failure. The release
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of CGRP has been observed from rat aortic strips upon exposure to HNO, which is a key factor to
cause visodilation.14 Cyanamide has been used as an alcohol deterrent agent. With the existence
of catalase and H2O2, cyanamide will release HNO as an aldehyde dehydrogenase (AIDH)
inhibitor.15 HNO can also be cytotoxic since it will affect the cellular function by changing redox
status of cell, but this process will be protected by GSH that works as an HNO scavenger.16
3.1.3 Possible endogenous HNO resources
A range of endogenous biomolecules can lead to the generation of HNO. Endogenous
generation of HNO could result from the reaction between H2S with NO has been suggested to
have a biological role in a HNO/TRPA1/CGRP pathway.11-12 The reaction between NH2OH and
NO could also be a endogenous resource for HNO, even with a low generation rate (5 × 10−3 M−1
s−1 at 25 ◦C, pH 7.3).17-18 Although free Fe (II) has a low concentration in biological systems, it is
still capable of reducing NO to HNO due to the stoichiometric conversion.19-20 The S-nitrosothiol
is another source for endogenous HNO upon the reaction with excess endogenous thiols at a
comparability low reaction rate (8.3 × 10−3 M−1 s−1).21 Meanwhile, the reaction of GSNO and
GSH22, GSNO and NADH23 also contribute to the generation of endogenous HNO. However, even
though the generation of HNO has been confirmed with isolated donors, the low reaction rate and
low concentration of the reactant limited the possibility of occurrence in biological system. As a
result, HNO detection methods have started to attract attention from researchers.
3.1.4 HNO detection methods and difficulties
The fast dimerization rate (k = 8 X 106 M–1s–1 at 23 ºC)2 and rapid reaction rate with
molecular oxygen (range from 103 to 104 M–1s–1)5, 24 for HNO in biological systems make its
detection challenging. Researchers have developed various methods to detect the biological HNO
reaction products instead of directly detecting HNO due to its instability. The dimerization product
N2O is a good indicator for HNO generation, which has been successfully detected by gas
chromatography and with electron paramagnetic resonance (EPR) spectroscopy trapping by Nmethyl-D-glucamine dithiocarbamate iron (Fe-MGD) to produce ERP active molecules.25 Even
though the detection of N2O is applicable in solution, but application of this method in biological
systems is limited. Glutathione sulfonamide, the product of HNO and GSH, can also be used as a
biomarker for HNO detection with high pressure liquid-chromatography mass spectrometry
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(HPLC-MS).26-27 However, sensitive tools for direct detection of HNO are needed to study
potential endogenous biological pathways and functions of HNO as well as measure HNO released
from pharmacological donor compounds.

3.1.5 Current HNO probes
A series of fluorescent HNO probes have been reported recently including copper-based
fluorescent probes,28 phosphine-based fluorescent probes,28 TEMPOL-based fluorescent probes28
and 2-mercapto-2-methylpropionic acid-based probes.45
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Scheme 3 - 1. Copper-based HNO fluorescent probe Cu(BOT1).30
The first small molecule fluorescent HNO probe was synthesized by Lippard’s group in
2010 based on the CuII cation (Scheme 3-1). When CuII is bounded to the tripodal dipicolylamineappended receptor, the fluorescence will be quenched. The CuII can quench the fluorescence of the
molecule by photoinduced electron transfer (PET) of the singlet excited state of BODIPY.
Cu(BOT1) has an 4-fold turn on towards 1000 equivalents of Angeli’s salt and a good selectivity
toward HNO.30 Later a series of probes based on copper has been synthesized with a turn-on range
of 5-fold to 15-fold at different emission wavelength.31-34 Another type of HNO probe has been
synthesized with phosphine as the protecting group.28 The fluorescence of the fluorophore is
quenched or diminished with the attachment of phosphine, and once reacted with HNO, the
phosphine protecting group will be removed and released the fluorophore with a higher fluorescent
emission.28 A series of probes based on this mechanism have been synthesized with different
emission wavelengths.35-43 Compared with Cu-based probes, phosphine-based probes present a
better fluorescent response. The metal free and reductant resistant trigger give it a better selectivity
for HNO detection in biological systems (Scheme 3-2).28 TEMPOL-based fluorescent probes44
and 2-mercapto-2-methylpropionic acid-based fluorescent probes45 also have been reported before.
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However, because of the instability of HNO in biological systems, a more sensitive tool for HNO
detection is needed to study the biological pathways and function of HNO. Compared with
fluorescent probes, chemiluminescent probes have a better signal-to-noise ratio, which could
significantly increase the detection sensitivity. Our lab designed and synthesized the first
chemiluminescent HNO probes, which have an over 800-fold increase toward 20 equivalents of
Angeli’s salt compared with the control. We successfully quantified the HNO generated from H2S
and NO and achieved HNO monitoring in biological systems.46 These results will be presented
and discussed in this chapter.
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3.2 Results and discussion
3.2.1 Design and Synthesis of HNOCL-1
Our lab aimed to develop highly sensitive probes as a powerful tool to detect and study the
generation, pathways and biological function of reactive oxygen and nitrogen species, and a series
of chemiluminescent probes based on 1,2-spirodioxetane have been synthesized and characterized
before1-4. Phosphine has been used as the HNO detection group for a series of probes5-10. The
design of HNOCL-1 consists of linking a triaryl phosphine group to the sterically stabilized 1,2dioxetane. By reacting with HNO, it will form a self-cleavable intermediate and release the
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phenolate. In aqueous solution, the phenolate will trigger Chemically Initiated Electron Exchange
Luminescence (CIEEL) mechanism and emit light.
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Scheme 3 - 3. Design and synthesis of HNOCL-1.
The synthesis of HNOCL-1 started with 2-chloro-3-methoxybenzaldehyde. First, we
treated the 4-chloro-3-methoxylbenzaldehyde 11 with trimethyl orthoformate the presence of ptoluenesulfonic acid in methanol to yield the acetal 12. The acetal 12 was treated with triethyl
phosphite and boron trifluoride diethyl etherate to obtain the diethyl methoxy phosphonate 13. We
ran the Horner–Wadsworth–Emmons reaction with phosphonate, where we treated 12 with n-BuLi
and 2-admantanone to yield the enol ether 14. The enol ether 14 would go through a demethylation
reaction via nucleophilic substitution with sodium ethanethiolate and cesium carbonate to obtain
the phenol 15. The enol ether was treated with N-iodosuccinimide, which yielded the iodide phenol
16. The iodide phenol 16 went through a Heck reaction and yielded the acrylate phenol 17. The
acrylate phenol 17 was dissolved with THF and Rose Bengal was added to the solvent as a catalyst.
O2 was then bubbled through the system and the 1,2-spirodioxetane phenol 18 was obtained.
Finally, the 1,2-spirodioxetane phenol 18 was treated with EDC, DMAP and 2diphenylphosphinobenzoic acid and yielded HNOCL-1 as product.
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3.2.2 Mechanism of HNO detection
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Scheme 3 - 4. Proposed mechanism for the reaction of the triaryl phosphine in HNOCL-1 with
HNO.
Once reacted with HNO, the HNOCL-1 will turn into a self-cleavable intermediate
azaylide which will lead to the ester cleavage and release the phenol. In aqueous solution, the
phenol will be deprotonated and yield the phenolate, which would decompose and trigger CIEEL.
The light emission for this compound is at 525 nm.47
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3.3.5 Quantification of HNO generated from NO and H2S
[HNO] = 1/(k 1[HNOCL-1]) (k 3[1] + d[1]/dt)

Eq. 3-1. Equation to quantify the concentration of HNO. [HNOCL-1] is the concentration of
HNOCL-1. [1] is the concentration of the phenol. k1 = 20,433 M–1s–1 at 25 ºC, pH 7.4 according
to the method developed by Miranda and Wink5. k3 = 5.92 X 10–4 s–1 at 25 ºC, pH 7.4 according
to measurements of the exponential decay of isolated 1.
Because of the sensitivity of HNOCL-1, we were able to quantify the concentration of
HNO generated from the system. The derivation of Eq. 3-1 is given in the Experimental Methods
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Figure 3- 5. (A) Time course of chemiluminescent emission and (B) integrated emission intensity
of 20 µM HNOCL-1 alone (blue trace), 200 µM Na2S alone or with 0.2, 0.5, and 1 mM (red trace)
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Na402S, 1 mM DN, and 2 mM N-acetyl cysteine (NAC). (C) Concentration of
Time / min
HNO produced from 20 µM HNOCL-1 alone (blue trace), and 200 µM Na2S and 0.2, 0.5, and 1
mM (red trace) DN as determined from Eq. (1) and the data shown in (A). All experiments were
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20

performed in 20 mM HEPES or PBS (pH 7.4), containing ≤1% DMSO. Error bars are + S.D.
from n = 3–6 replicates.

With HNOCL-1, we successfully confirmed and quantified the generation of HNO from
H2S and NO, which is one of the possible endogenous sources of HNO. With 200 µM Na2S and
20 µM HNOCL-1, a significant rise in chemiluminescent emission appeared with the addition of
DEA NONOate. It shows a dose-dependent manner with different concentrations of DEA
NONOate. With the increasing concentration of DEA NONOate, the maximum emission increased
and it takes shorter time to reach the emission peak (Figure 3-5, A). Once we added the N-acetyl
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washed and incubated without (blue trace) or with 1 mM DEA NONOate (DN) and 200 µM Na2S
(red trace). (B) Integrated emission intensity of A549 cells incubated with 20 µM HNOCL-1 for
30 minutes, washed and treated as indicated with H2S as 200 µM Na2S, NO as 1 mM DN, and
20
30
NAC
at402 mM. Error bars are +S.E. from n = 6–11 wells and 2–4 biological replicates. Statistical
Time / min
significance was assessed using a two-tailed student's t-test. **p<0.01, *p<0.05. All cellular
experiments were performed at 37 ºC.

We then continued to test if HNOCL-1 had the ability to detect the HNO generated from
the reaction between H2S and NO in biological system. After 30 mins incubation with HNOCL1, the Na2S and DEA NONOate were added to the A549 lung cancer cells. The experimental group
showed a slight rise compared to the control group. Upon the addition of N-acetyl cysteine (NAC)
to the cells treated with Na2S and DEA NONOate, there was a significant decrease in the emission.
These results demonstrated that HNOCL-1 has the ability to detect the HNO generated from Na2S
and NO in a biological system.
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3.3.7 HNO in vivo detection
(A)

(B)

Figure 3- 8. Images of BALB/c nude mice 2 minutes after IP injection with 40 µM HNOCL-1
and (A) vehicle control or (B) 1 mM Angeli's salt in 20 mM PBS (pH 7.4) containing 5% DMSO.
We also investigated the ability for HNOCL-1 to detect HNO in vivo. We conducted the
experiments in the BALB/c nude mice. From the results, the chemiluminescence emission from
the experimental group with 1 mM AS and 40 µM HNOCL-1 increase 300-fold compared with
the vehicle control. This result shows that HNOCL-1 has promise for pharmacological HNO
detection in vivo.

3.3 Conclusions
In summary, we have described the first chemiluminescent probe for real-time monitoring
of HNO in living cells. The rapid and sensitive response has enabled an innovative kinetics-based
approach that provides quantitative estimates of HNO concentration. To date, this has only been
accomplished using electrodes and a xerogel optical sensor film, which are inherently limited to
extracellular monitoring. Chemiluminescent probes like HNOCL-1 can be loaded into cells, and
we anticipate that expansion of this kinetics-based approach will lead to a unique method for
quantification of HNO in living cells. This approach is generalizable to other reaction-based probes
as long as one can achieve high sensitivity, mechanistic understanding, and evaluation of kinetic
parameters. The cellular data shows that HNOCL-1 provides a method to reliably monitor the
time-course of HNO delivery from donor systems and preliminary experiments in living mice
demonstrate that the high photon flux from HNOCL-1 is sufficient for imaging HNO in animal
tissue. We anticipate that HNOCL-1 will find use in understanding HNO biology and the
development of new HNO-based therapeutics.
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3.4 Experimental Methods
3.4.1 General synthetic materials and methods.
All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel
P60 (SiliCycle) was used for column chromatography and Analytical Chromatography TLC Silica
gel 60 F254 (Merck Millipore, Darmstadt, Germany) was used for analytical thin layer
chromatography. Plates were visualized by fluorescence quenching under UV light or by staining
with iodine. N,N-Diisopropylethylamine was distilled from potassium hydroxide, but all other
reagents were used without further purification. Anhydrous dimethylformamide was used in all
reactions. Other reagents were purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward
Hill, MA), EMD Millipore (Billerica, MA), Oakwood Chemical (West Columbia, SC), or TCI
(Tokyo, Japan) and used without further purification. 1H NMR and

13

C NMR spectra for

characterization of new compounds and monitoring reactions were collected in CDCl3 (Cambridge
Isotope Laboratories, Cambridge, MA) on a JEOL 500 MHz spectrometer in the Department of
Chemistry at Southern Methodist University. All chemical shifts are reported in the standard
notation of parts per million using the peak of residual proton signals of the deuterated solvent as
an internal reference. Coupling constant units are in Hertz (Hz) Splitting patterns are indicated as
follows: br, broad; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublets;
dt, doublet of triplets. Chemical abbreviations are used as follows: CH2Cl2, dichloromethane;
EtOAc, ethyl acetate; THF, tetrahydrofuran; DMF, dimethylformamide; H2O, water; HBTU, Obenzotriazole-N,N,N’,N’-tetramethyl-

uronium-hexafluoro-

phosphate;

DIPEA,

N,N-

diisopropylethylamine; KOH, potassium hydroxide; DMSO, dimethylsulfoxide N2, nitrogen. High
resolution mass spectroscopy was performed on a Shimadzu IT-TOF (ESI source) and low
resolution mass spectroscopy was performed on a Shimadzu LCMS-8050 Triple Quadrupole
LCMS (ESI source) or a Shimadzu Matrix Assisted Laser Desorption/Ionization MS (MALDI) at
the Shimadzu Center for Advanced Analytical Chemistry at the University of Texas, Arlington.
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OMe
O
P
OEt
EtO
Cl
OMe
12

(12). 2-Chloro-3-methoxybenzaldehyde (9900 mg, 58.6 mmol, 1 equiv) was dissolved with 80 mL
MeOH in a dry flask filled with N2. Trimethyl orthoformate (6.4 mL, 59 mmol, 1.0 equiv) and pToluenesulfonic acid (1009 mg, 5.9 mmol, 0.1 equiv) was added to the flask. The mixture was
stirred for 24 hours at room temperature under N2. After that the mixture was neutralized by NEt3.
300 mL NaHCO3 was poured into the mixture and extract with 3 x 300 mL EtOAc. The organic
layer was dried by Na2SO4, filtered and concentrated under reduced pressure to obtain crude acetal
11 (1897 mg). Compound 11 was dissolved in 20 mL DCM at 0 °C. Triethyl phosphite (10.5 mL,
61.1 mmol, 1.0 equiv) and boron trifluoride etherate (7.7 mL, 61.1 mmol, 1.0 equiv) were added
to the flask at 0 °C and stir for 20 mins. The reaction was raised to 30 °C and stirred for 2 hours.
The reaction was quenched by 50 mL NaHCO3, extracted by 3 x 50 mL EtOAc and dried by
Na2SO4 and filtered. The EtOAc was evaporated under reduced pressure and purified by column
chromatography (1:15 EtOAc/Hexane) yield the product as a pale yellow oil 12 (1339 mg, >95 %).
1

H NMR (500 MHz, CDCl3) d 7.29 (m, 2H), 6.91 (m, 1H), 5.19 (d, 1H, J = 15.0 Hz), 4.17–4.21

(m, 4H), 4.16 (s, 3H), 3.34 (s, 1H), 1.31–1.35 (t, 3H, J = 6.8 Hz), 1.19–1.24 (t, 3H, J = 6.8 Hz);
13

C NMR (125 MHz, CDCl3) d 156.41, 135.67, 128.82, 124.33, 122.63, 113.16, 77.04, 64.66,

64.57, 60.26, 57.73, 17.91, 17.80.
OMe Cl
OMe

13

(13). Compound 12 (19351 mg, 60 mmol, 1.0 equiv) was dissolved in 30 mL anhydrous THF in
a dry flask under N2 and cooled to –78°C by adding dry ice to acetone. 2-Adamantanone (11174
mg, 72.0 mmol, 1.2 equiv) was dissolved in 30 mL anhydrous THF and cooled to –78 °C. 30.0 mL
1.6 M n-BuLi was added to the compound 12 solvent at –78 °C and stirred for 20 min. The cooled
2-adamantanone solution was added to the flask and the temperature of the reactants was raised to
30 °C. The mixture was stirred for 2 hours and the temperature was raised to 90 °C under reflux.
After 1 hour reflux, the reaction was quenched by 100 mL NH4Cl and extracted by 3 x 100 mL
EtOAc. Purification by chromatography (1:20 EtOAc/Hexane) yielded compound 13 as a colorless
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oil (17320 mg, 91%). 1H NMR (400 MHz, CDCl3) d 7.25 (t, 1H, J = 7.6 Hz), 6.89–6.94 (m, 2H),
3.95 (s, 3H), 3.34 (s, 3H), 3.32 (s, 1H), 1.62–2.10 (m, 12H); 13C NMR (125 MHz, CDCl3) d 155.28,
139.91, 136.12, 131.17, 126.80, 124.09, 123.16, 111.24, 57.05, 56.27, 47.06, 39.35, 38.71, 37.24,
37.06, 34.68, 33.07, 32.91, 29.67.
OMe Cl
OH

14

(14). Compound 13 (4662 mg, 14.6 mmol, 1.0 equiv) was dissolved in 35.0 mL anhydrous DMF
at room temperature in a dry flask under N2. Cs2CO3 (5781 mg, 17.6 mmol, 1.2 equiv) and EtSNa
(1496 mg, 17.6 mmol, 1.2 equiv) was added to the flask. The temperature of the mixture was raised
to 90 °C under reflux for 18 hours. The reaction was quenched by 200 mL of NH4Cl, extracted by
3 x 200 mL. The mixture was washed with 3 x 200 mL brine to remove the extra DMF and the
organic layer was dried over Na2SO4 and evaporated under reduced pressure. Purification by
column chromatography (1:19 EtOAc:Hexane) yielded compound 14 as a white solid (3657 mg,
82%). 1H NMR (500 MHz, CDCl3) d 7.14 (t, 1H, J = 8 Hz), 6.98 (dd, 1H, J1 = 10.0 Hz, J2 = 2.5
Hz), 6.82 (dd, 1H, J1 = 7.5 Hz, J2 = 1.15 Hz), 3.30 (s, 3H), 3.27 (s, 1H), 1.70–1.93 (m, 12H); 13C
NMR (125 MHz, CDCl3) d 151.79, 139.79, 135.06, 131.91, 127.38, 123.96, 120.64, 115.54, 57.16,
47.04, 39.35, 38.71, 37.18, 36.37, 34.61, 33.24, 32.89, 29.72.
OMe Cl
OH
I
15

(15). Compound 14 (4584 mg, 15.0 mmol, 1 equiv) was dissolved with 70 mL toluene at –5 °C.
The NIS (3391 mg, 15.0 mmol, 1 equiv) was added to the solvent later and the mixture was stirred
at 0 °C for 50 mins. The mixture was washed with 100 mL brine to quench the reaction and extract
with 3 x 200 mL EtOAc. Several pieces of Na2S2O3 crystals were added to the mixture to remove
the extra iodine. The color of the mixture was changing during the work-up. It turned from red to
brown, later to orange and finally the organic layer ended up with light yellow. The organic layer
was later dried trough Na2SO4 and the solvent was removed under reduced pressure. A pale dark
yellow oil was obtained and purified by washed with pure Hexane. A white solid will be obtained
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after wash (3818 mg, 59%). 1H NMR (500 MHz, CDCl3) d 7.60 (d, 1H, J = 8 Hz), 6.09 (d, 1H, J
= 8.0 Hz), 3.30 (s, 3H), 3.25 (s, 1H), 2.08 (s, 1H), 1.72–1.94 (m, 12H);

13

C NMR (125 MHz,

CDCl3) d 177.03, 151.19, 144.48, 139.23, 136.78, 135.77, 132.69, 130.38, 127.38, 125.28, 120.07,
99.03, 82.23, 57.31, 37.11, 32.93, 29.66, 28.40.
OMe Cl
OH
CN
16

(16). Compound 15 (300 mg, 0.7 mmol, 1 equiv), and Pd(OAc)2 (7.8 mg, 0.04 mmol, 0.05 equiv)
was added to the microwave reaction tube and fill the tube with N2. Dessolve the mixture with 1.0
mL MeCN. Later TEA (0.15 mL, 1.0 mmol, 1.5 equiv) was added to the tube and all the solid was
dissolving upon the addition. Acrylonitrile (0.14 mL, 2.1 mmol, 3 equiv) was added to the mixture
later. The tube was put into the microwave and set the temperature to 120 °C for 70 mins. When
the reactants cooled down to the room temperature, add 30 mL saturated NH4Cl to it. The 3 x 30
mL EtOAc was added to the mixture to extract the product. The organic layer was later dried
through Na2SO4 and the solvent was removed under reduced pressure. A brown oil was obtained
after the evaporation. Purification of the product is through the column chromatography with pure
DCM and a light yellow sold was obtained. (101 mg, 41%). 1H NMR (400 MHz, CDCl3), d 7.60
(d, 1H, J = 16 Hz), 7.30 (d, 1H, J = 8 Hz), 6.91 (d, 1H, J = 4 Hz), 6.38 (s, 1H), 6.20 (s, 1H, 1H, J
= 16 Hz), 3.33 (s, 3H), 3.29 (s, 1H), 2.12 (s, 1H), 1.98–1.78 (m, 12H); 13C NMR (125 MHz, CDCl3)
d 150.45, 145.26, 139.08, 137.43, 133.36, 126.71, 123.74, 120.96, 118.51, 98.59, 57.38, 39.15,
39.01, 38.84, 38.71, 38.57, 36.93, 32.87, 29.69, 28.19.

O

O OMe Cl
OH
CN
17

(17). Compound 16 (101 mg, 0.3 mmol, 1.0 equiv) and Rose Bengal (22.2 mg, 0.02 mmol, 0.07
equiv) were added into a dry two-neck flask and dissolved in 5 mL THF. O2 was bubbled through
the solvent while illuminated with a 120W light bulb (Home Depot, Dallas, TX) at 0–5°C. Monitor
the reaction by TLC. After 1 hour, the mixture was concentrated at 0 °C. Purification by silica
column chromatography (1:19 EtOAc/Hexane) delivered compound 17 as a light yellow solid
(71.8 mg, 65 %). 1H NMR (400 MHz, CDCl3), d 7.73 (d, 1H, J = 4 Hz), 7.63 (d, 1H, J = 16 Hz),
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7.45 (d, 1H, J = 4 Hz), 6.59 (s, 1H), 6.26 (d, 1H, J = 16 Hz), 3.24 (s, 3H), 3.04 (s, 1H), 2.05 (s,
1H), 1.89–1.59 (m, 12H). 13C NMR (125 MHz, CDCl3) d. 150.69, 144.77, 134.74, 126.82, 124.84,
122.80, 118.18, 111.40, 99.99, 96.28, 49.68, 36.42, 34.01, 33.42, 32.79, 32.08, 31.49, 26.04,
25.70.54
O

O OMe Cl

Ph2P
O
O

HNOCL-1
CN

2-Chloro-6-((E)-2-cyanovinyl)-3-((1r,3r,5r,7r)-4'-methoxyspiro[adamantane-2,3'[1,2]dioxetan]-4'-yl)phenyl 2-(diphenylphosphaneyl)benzoate (HNOCL-1). The compound 2(diphenylphosphino) benzoic acid (12.4 mg, 0.039 mmol, 1 equiv) was added to a dry, N2 filled
flask and dissolved with 5.0 mL CH2Cl2. Dimethylaminopyridine (6.0 mg, 0.048 mmol, 1.25 equiv)
and N-(3-dimethylaminopropyl)-N'-ethylcarbodimiide hydrochloride (8.0 mg, 0.039 mmol, 1.0
equiv) were added to the flask. The mixture was stirred at room temperature for 5 min. The
compound 17 (15.0 mg, 0.039 mmol, 1.0 equiv) was dissolved in 2.0 mL CH2Cl2 and added to the
mixture. The reaction was stirred at ambient temperature for 2 hr. The reaction was quenched by
30 mL saturated NH4Cl and extracted with 3 x 30 mL CH2Cl2. The organic layer was dried with
Na2SO4, filtered and concentrated. Purification by silica column chromatography (10:1
Hexane:EtOAc) yielded HNOCL-1 (12.9 mg, 49%) as a white solid. 1H NMR (500 MHz, CDCl3)
δ 8.39–8.38 (m, 1H),) 7.94 (d, 1H, J = 8.5 Hz), 7.46–7.44 (m, 4H), 7.28–7.18 (m, 10H), 6.96–6.95
(m, 1H), 5.85 (d, 1H, J = 17.1 Hz), 3.06 (s, 3H), 2.91 (s, 1H), 1.85–1.35 (m, 13H); 13C NMR (125
MHz, CDCl3δ 146.48, 143.08, 137.04, 136.96, 136.00, 134.54, 134.23, 134.05, 133.98, 133.91,
133.82, 133.66, 133.51, 132.10, 130.63, 130.04, 129.02, 128.64, 128.59, 128.46, 127.33, 124.09,
117.29, 111.39, 100.86, 96.36, 49.80, 39.22, 36.49, 33.80, 33.54, 32.09, 31.54, 31.47, 30.92, 26.08,
25.63; HRMS calcd for C40H35NO5PCl [M+Na]+ 698.1834 m/z, found 698.1854.
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Scheme 3 - 6. Synthesis of the fluorescent HNO probe, XF2.
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Ethyl 2-((3'-hydroxy-3-oxo-3H-spiro [isobenzofuran-1,9'-xanthen]-6'-yl)oxy)acetate (3).
Fluorescein (600 mg, 1.81 mmol, 1.0 equiv) was dissolved in 5 mL of DMF. DIPEA (0.94 mL,
5.4 mmol, 3.0 equiv) was added and the reaction mixture was stirred for five minutes. Ethyl
bromoacetate (0.40 mL, 3.6 mmol, 2.0 equiv) was added. The reaction was stirred at rt for 5 h.
The reaction mixture was poured into a separatory funnel containing 100 mL of CH2Cl2, washed
with 85 mL H2O and 40 mL of brine. The organic layer was dried over sodium sulfate, filtered,
and concentrated. The resulting product was purified by silica gel column chromatography (1:1
Hexanes:EtOAc) to afford the ethyl acetate fluorescein 3 (182 mg, 24% yield). 1H NMR (500 MHz,
CDCl3) d 8.03 (d, 1H, J = 6.3 Hz), 7.67 (td, 1H, J = 6.3, 1.2 Hz), 7.62 (t, 1H, J = 7.4 Hz), 7.16 (d,
1H, J = 7.4 Hz), 6.75–6.25 (m, 5H), 6.53 (dd, 1H, J = 8.6, 2.9 Hz), 5.21 (s, 1H), 4.65 (s, 2H), 4.29
(q, 2H, J = 6.8 Hz), 1.31 (t, 3H, J = 6.7 Hz); 13C NMR (125 MHz, CDCl3) d 169.95, 168.61, 159.47,
157.97, 153.17, 152.47, 135.24, 129.86, 129.43, 126.76, 125.13, 124.01, 112.47, 112.37, 111.77,
103.22, 102.06, 65.48, 61.75, 14.25; HRMS calcd for C24H18O7 [M+Na]+ 441.0945, found
441.0928.

75

PPh2
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3'- (2 - Ethoxy - 2 - oxoethoxy) - 3 - oxo - 3H - spiro[isobenzofuran - 1,9' - xanthen] - 6' - yl 2(diphenylphosphanyl) benzoate (XF2). 2-(diphenylphosphino)benzoic acid (74.7 mg, 0.244
mmol, 1.0 equiv) and HBTU (111 mg, 0.293 mmol, 1.2 equiv) were dissolved in 5 mL of DMF.
DIPEA (0.190 mL, 1.01 mmol, 4.1 equiv) was added and the reaction was stirred for 5 min.
Compound 3 (99.3 mg, 0.243 mmol, 1.0 equiv) was added and the reaction was stirred at rt for 2.5
h. The reaction mixture was poured into a separatory funnel containing 50 mL of CH2Cl2, washed
with 3 x 50 mL H2O and 50 mL of brine. The organic layer was dried over sodium sulfate, filtered,
and concentrated. The resulting product was purified by silica gel column chromatography (3:2
Hexanes:EtOAc) to afford XF2 (37.3 mg, 29% yield) as a clear oil. 1H NMR (500 MHz, CDCl3)
d 8.26–824 (m, 1H), 8.02 (d, 1H, J = 7.5 Hz), 7.67 (td, 1H, J = 7.5, 1.2 Hz), 7.62 (t, 1H, J = 7.5
Hz), 7.48–7.36 (m, 2H), 7.37–7.26 (m, 10H), 7.14 (d, 1H, J = 7.4 Hz), 7.01–6.98 (m, 1H), 6.96 (d,
1H, J = 2.3 Hz), 6.76–6.61 (m, 5H), 4.64 (s, 2H), 4.29 (q, 2H, J = 6.9 Hz), 1.31 (t, 3H, J = 6.9 Hz);
13

C NMR (125 MHz, CDCl3) d 169.28, 168.30, 164.70, 159.49, 152.95, 152.12, 151.77 151.64,

141.70, 141.47, 137.44, 137.36, 135.15, 134.49, 134.08, 133.90, 133.02, 132.76, 131.40, 129.87,
129.27, 128.89, 128.84, 128.61, 128.55, 128.35, 126.34, 125.08, 124.06, 117.60, 116.57, 112.02,
110.47, 101.90, 82.23, 65.42, 61.61, 14.16; HRMS calcd for C43H31O8P [M+H]+ 707.1829, found
707.1831.

3.4.2 Chemiluminescence response of HNOCL-1.
Chemiluminescence responses and time scans were acquired with a Hitachi F-7000 Fluorescence
Spectrophotometer (Hitachi, Tokyo, Japan, Figures 3-1 A, 3-1, 3-3 B) using the luminescence
detection module or a Cytation 5 BioTek plate reader (Winooski, VT, Figures 3-1 B, 3-3 A, 3-4
A, 3-6 A, 3-7 A) using the luminescence detection method, endpoint read type, and setting gain to
135 and operating at ambient temperature (25–28 ºC). 20 mM PBS buffer (pH 7.4), 5 mM
HNOCL-1 stock solution in DMSO (20 µM final concentration) and Angeli’s salt were added to
a quartz cuvette (Starna, Atascadero, CA) or multi-well plate in sequence. Samples were shaken
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gently to assure mixing. For spectral scans, 20 μM HNOCL-1 was treated with 0, 50, 100, 150
and 200 μM Angeli’s salt and measured in a fluorescence spectrometer. Time scans were acquired
using the plate reader with 0, 5, 25, 50, and 100 µM Angeli’s salt. The time between adding
Angeli's salt and beginning the measurement was recorded and was between 20 and 100 seconds.
3.4.3 GC/MS determination of HNOCL-1 products.
A 5.1 mM stock solution of Angeli’s salt was made by dissolving Angeli’s salt in 0.01 mM NaOH,
and the final concentration was confirmed by UV/Vis by measuring the absorbance at 237 nm (e
= 6100 M–1 cm–1). 1.3 mg (0.0019 mmol) of HNOCL-1 was dissolved in 10.0 mL acetone in a 20
dram vial. 9.62 mL of 20 mM PBS buffer (pH = 7.4) and 0.38 mL of 5.1 mM Angeli’s salt solution
were added to make a final concentration of 95 µM HNOCL-1 with 95 µM Angeli’s salt. A stir
bar was added, and the solution was capped and stirred at room temperature for 24 hours. The
solution was poured into a separatory funnel, washed with brine, and the organic layer was
extracted with 3 x 15 mL EtOAc. The organic layer was evaporated under reduced pressure, and
the leftover contents were dissolved in 1.5 mL CH2Cl2 and pipetted into a GC/MS vial. GC/MS
was conducted immediately using a 6850 Series GC/MS (Agilent Technologies, Santa Clara, CA).
Mass spectra were averaged across the major peaks in the chromatogram and molecular ions for
m/z = 150.1 (Figure 3-9) and m/z = 304.1 (Figure 3-10) were found. The spectrum of 2adamantanone was matched against the NIST standard, which can be found via web at:
https://webbook.nist.gov/cgi/cbook.cgi?ID=C700583&Units=CAL&Mask=200#Mass-Spec,
accessed September 26, 2018.
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Figure 3- 9. Mass spectrum of the peak assigned to adamantanone. Inset is the NIST standard.
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Figure 3- 10. Mass spectrum of the peak assigned to the acyl iminophosphorane.
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3.4.4 Solubility and stability studies.
Solutions of 20, 40, 60, 80, and 100 µM HNOCL-1 were prepared in 20 mM PBS (pH = 7.4)
containing 1% DMSO. The precipitation was evaluated by measuring the raise in the baseline
absorbance at 750 nm (Figure 3-11). In order to evaluate stability, 20 µM HNOCL-1 was preincubated in 20 mM PBS (pH 7.4) containing ≤ 1% DMSO for 0, 60, or 120 minutes before treating
with 200 µM Angeli's salt. The time-course of the chemiluminescence emission was measured
using a Cytation 5 BioTek plate reader (Figure 3-12).
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Figure 3- 11. Solubility of HNOCL-1. (A) Photographs of cuvettes containing 20, 60, and 100
µM HNOCL-1 in 20 mM PBS buffer containing ≤ 1% DMSO. (B) Absorbance at 750 nm of 20–
100 µM HNOCL-1 in 20 mM PBS buffer containing ≤ 1% DMSO. Error bars are ± S.D. from n
= 3 replicates.
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Figure 3- 12. Stability of HNOCL-1. 20 µM HNOCL-1 was pre-incubated in 20 mM PBS (pH
7.4) containing ≤ 1% DMSO for 0 (blue trace), 60 (black trace), or 120 (red trace) minutes before
treating with 200 µM Angeli's salt. Error bars are ± S.D. from n = 3 replicates
3.4.5 Determination of the detection limit for HNOCL-1
Chemiluminescence responses were measured using a Cytation 5 BioTek plate reader (Winooski,
VT) by using the luminescence detection method, endpoint read type, and setting gain to 135 and
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temperature to 30 °C. A 0.3016 mM stock solution of Angeli’s salt was made by dissolving
Angeli’s salt with 0.01 mM NaOH, and the final concentration was confirmed by UV/Vis by
measuring the absorbance at 237 nm (e = 6100 M–1 cm–1). An aliquot of 1 µL of a 5 mM HNOCL1 stock solution (final concentration of 20 µM) was added to each well, filled with the appropriate
volume of 20 mM PBS buffer for a final volume of 250 µL in each well. Finally, Angeli's salt was
added to each well to give final concentrations of 0, 0.25, 0.5, 1, 1.5, and 2 µM Angeli's salt. The
emission was integrated over 20 minutes and the calibration curve was constructed using
experiments replicated on two different days, for a total of 6 replicates for each data point (3
replicates for 0.25 and 2 µM). The detection limit (3s/k) was determined as 138 nM, which,
according to kinetic simulations (see section 4. Kinetics), generates concentrations of less than 50
pM HNO.
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3.4.6 Response and selectivity
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Figure 3- 14. (A) Fluorescence response of 10 µM XF2 to 200 µM Angelis' salt. Time points
represent 0, 1, 5, 10, 15, 20, and 25 min after addition of 200 µM Angeli's salt. (B) Fluorescence
response of 10 µM XF2 to 200 µM biologically relevant reactive oxygen and nitrogen species.
Emission was collected from 508 and 650 nm. Legend: (1) AS; (2) H2S; (3) ONOO–; (4) NaOCl;
(5) H2O2; (6) GSH (5 mM); (7) GSNO; (8) DEA NONOate; (9) tBuOOH. Data were acquired in
20 mM HEPES buffer (pH 7.4) at 21 °C with excitation at lex = 488 nm. Bars represent fluorescent
emission at 508 nm, and 1, 5, 10, 15, 20, 25, and 30 minutes after addition of the analyte. Error
bars are ± S.D. from n = 3 replicates.
Selectivity for XF2 was performed using an F-7000 fluorescence spectrophotometer (Hitachi,
Tokyo, Japan) and monitored every 5 minutes for 30 minutes. UV/Vis measurements were
acquired on a DU-800 spectrophotometer (Beckman Coulter, Brea, CA). Reactions were
performed as triplicates. All probe aliquots were prepared as 5 mM stock solutions in DMF and
the selectivity reactions were performed in 20 mM HEPES (pH 7.4).
Blank: 2 μL of 5 mM XF2 was added to 998 μL of 20 mM HEPES (10 µM final concentration).
AS: 2 μL of 5 mM or XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration),
and 20 μL of 10 mM AS (confirmed by UV-Vis) was added to the mixture (200 µM final
concentration).
H2S: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), and
20 μL of 10 mM Na2S in H2O was added to the mixture (200 µM final concentration).
NaOCl: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration),
and 20 μL of 10 mM NaOCl in H2O was added to the mixture (200 µM final concentration).
H2O2: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration),
and 20 μL of 10 mM H2O2 was added to the mixture (200 µM final concentration).
Glutathione: 2 μL of 5 mM XF2 was added to 898 μL of 20 mM HEPES (10 µM final
concentration), and 100 μL of 50 mM glutathione was added to the mixture to make final
concentration of 5 mM for glutathione.
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S-nitrosoglutathione: S-nitrosoglutathione (GSNO) was synthesized and characterized using a
literature procedure.48 Approximately 1 mg of GSNO was dissolved in 1 mL DI H2O, and the
precise concentration was measured by UV/Vis using the absorptions at 335 nm (ε = 922 M-1 cm1

) or 545 nm (ε = 15.9 M-1 cm-1). The solution was made on a daily basis and kept at 0 oC. 2 μL of

5 mM XF2 was added to 982.1 μL of 20 mM HEPES (10 µM final concentration), and 15.9 μL of
12.58 mM S-nitrosoglutathione was added to the mixture (200 µM final concentration).
ONOO–: ONOO– was synthesized based on an adaptation of a literature procedure,49 by adding
0.24 mL of H2O2 (35% wt. in H2O, 2.8 mmol, 1.4 equiv) to a round bottom flask containing 4.5
mL of 0.55 M NaOH and 5 mL isopropyl alcohol. Isoamyl nitrite (0.27 mL, 2.0 mmol, 1.0 equiv)
was added, and stirred at rt for 15 minutes. MnO2 (10 mg, 0.12 mmol) was added to the reaction
and stirred for extra 5 minutes to decompose excess H2O2. The reaction mixture was filtered to
remove MnO2 and washed four times with 10 mL of DCM in a separatory funnel. The aqueous
layer was removed with a Pasteur pipet to avoid having any DCM. The concentration was
determined by UV/Vis using the absorption at 302 nm (ε = 1670 M-1 cm-1), and was diluted to
make a 10 mM stock solution. 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM
final concentration), and 20 μL of 10 mM ONOO– was added to the mixture (200 µM final
concentration).
DEA NONOate: A stock solution of DEA NONOate (Cayman Chemical, Ann Arbor, Michigan)
was prepared in 0.01 M NaOH and the precise concentration was measure by UV/Vis using the
absorption at 250 nm (ε = 6500 M-1 cm-1), and diluted to a final concentration of 10 mM. 2 μL of
5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), and 20 μL of 10
mM DEA NONOate was added to the mixture (200 µM final concentration).
t

BuOOH: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration),

and 20 μL of 10 mM tBuOOH was added to the mixture (200 µM final concentration).

82

3.4.7 Kinetics
General methods. Chemiluminescent responses were measured using a Cytation 5 BioTek plate
reader (Winooski, VT) using the luminescence detection mode, end point read type. Measurements
were made at ambient temperature (25–28 °C), the gain was set at 135, and the height was set at
4.5 mm.

Derivation of equation (1). The reactions between HNOCL-1 and HNO used to model triggered
chemiluminescence are shown in Scheme 3-8 and the derivation of equation (1) is given in
reactions (2) – (4) and equations (5) – (12).
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Scheme 3 - 7. Reactions for chemiluminescence emission of HNOCL-1.
[HNOCL-1] + [HNO]
[2]
[1]

k2
k3

k1

[2]

(2)

[1]

(3)

hn + products

(4)

d[HNO]/dt = –k 1[HNOCL-1][HNO]

(5)

d[2]/dt = k 1[HNOCL-1][HNO] – k 2[2]

(6)

d[1]/dt = k 2[2] – k 3[1]

(7)

[HNO] = 1/(k 1[HNOCL-1]) (k 2[2] + d[2]/dt)

(8)

[2] = 1/k 2 (k 3[1] + d[1]/dt)

(9)

d[2]/dt = 1/k 2 (k 3d[1]/dt + d2[1]/dt2)

(10)

[HNO] = 1/(k 1[HNOCL-1]) (k 3[1] + d[1]/dt + (1/k 2) (k 3d[1]/dt + d2[1]/dt2))

(11)
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[HNO] = 1/(k 1[HNOCL-1]) (k 3[1] + (1+ k 3/k 2) d[1]/dt + (1/k 2) d2[1]/dt2)

(12)

[HNO] = 1/(k 1[HNOCL-1]) (k 3[1] + d[1]/dt)

(1)

The reaction between the triaryl phosphine in HNOCL-1 and HNO forms an azaylide intermediate
2 in reaction (2) with a rate defined by equation (6). While it takes two equivalents of probe to
form product, we use an observed second order rate constant, k1, determined as described below.
Since the concentration of probe is constant throughout all experiments in this manuscript, the
observed second order rate constant will be consistent with this model. The nucleophilic nitrogen
of 2 mediates ester cleavage to form the phenol 1 in the intramolecular reaction (3) with a rate
defined by equation (7). Finally, 1 decomposes via a chemically initiated electron exchange
luminescence (CIEEL) mechanism in reaction (4) with a rate also defined by equation (7).
Equation (6) can be reorganized into equation (8) to provide [HNO] in terms of [2] and d[2]/dt and
equation (7) can be reorganized into equation (9) to provide [2] in terms of [1] and d[1]/dt, which
is differentiated to give equation (10). Substitution of equations (9) and (10) into equation (8)
provides equation (11), which can be reorganized into equation (12). Here, we make two key
assumptions:
1. If k3 << k2 (this is true if the chemiluminescent decomposition is rate-limiting) and the second
derivative d2[1]/dt2 is small, then equation (12) simplifies to equation (1).
2. [HNOCL-1] >> [HNO], and so [HNOCL-1] can be approximated as constant over the course
of the reaction.
In order to use equation (1) to obtain [HNO] from the relative chemiluminescent emission we need
to know k1, k3, [1], and d[1]/dt.
Measurement of k1. The value of k1 was measured by a method similar to that of Miranda and
Wink5 by looking at the chemiluminescence response of HNOCL-1 with increasing
concentrations of Angeli's salt. Due to instrumental limitations, experiments were performed under
aerobic conditions, so the relevant rate is defined by equation (13), where kD is the rate of HNO
dimerization, k1 is the rate of reaction of the probe with HNO, kO2 is the rate of reaction of O2 with
HNO, and kAS is the rate of the decomposition of Angeli's salt (AS).
d[HNO]/dt = –2k D[HNO]2 – k 1[HNOCL-1][HNO] – k O2[O 2][HNO] + k AS [AS]

(13)
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Using the steady state approximation and applying the quadratic equation gives:
[HNO] = (k 1[HNOCL-1] + k O2[O 2]) ± ((k 1[HNOCL-1] + k O2[O 2]) 2 – 4(–2k D)k AS [AS])1/2
2*(–2k D)

(14)

As the concentration of Angeli's salt is increased, dimerization is the main competitive reaction.
At the concentration of Angeli's salt that gives 50% product formation versus competitive HNO
dimerization, the rates are equal and equation (15) holds as derived by Miranda and Wink.5
k 1 = –2k D [HNO]/[HNOCL-1]

(15)

Substitution into equation (14) gives equation (16), which simplifies (after reorganization and
application of the quadratic equation) to equation (17).
k1 =

2k D

* (k 1[HNOCL-1] + k O2[O 2]) ± ((k 1[HNOCL-1] + k O2[O 2]) 2 – 4(–2k D)k AS [AS]) 1/2

[HNOCL-1]

2*(–2k D)

k 1 = –([O 2]k O2) ± (([O 2]k O2) 2 + 16k Dk AS [AS]) 1/2
4[HNOCL-1])

(16)

(17)

The concentration of Angeli's salt needed for 50% product formation was found to be 0.148 mM
from the experiment shown in Figure 3-15.
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Figure 3- 15. Initial value of the relative emission intensity of 20 µM HNOCL-1 and 0, 0.2, 0.5,
1, 2, and 4 mM Angeli's salt in pH 7.4 PBS buffer at 25 ºC. Error bars are ± S.D. from n = 3
replicates.

Other values were used as reported in the literature:
kO2 = 18,000 M–1s–1 at 25 ºC50
[O2] = 225 µM50
kAS = 0.00084 s–1 at 25 ºC50
kD = 8,000,000 M–1s–1 at 23 ºC51
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[HNOCL-1] = 20 µM
Substituting these values into equation (17) gives a rate constant k1 = 20,433 M–1 s–1 at 25 ºC and
pH 7.4.

Measurement of k3 and calibration of [1]. The rate of chemiluminescent decomposition, k3, was
determined from monitoring the chemiluminescence emission of isolated 1 over time to yield a
value of k3 = 5.92 ± 0.32 x 10–4 s–1 at 25 ºC and pH 7.4 (Figure 3-16, A). The rate was independent
of the concentration of 1, and this reported value is the average of the value determined at different
concentrations of 1. Plotting the initial value of the chemiluminescence emission versus the
concentration of 1 provided a linear calibration plot to convert the relative emission intensity into
[1]. The calibration was performed on four separate days and the average values were used to
construct the plot in Figure 3-16, B.
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Figure 3- 17. Quantification of HNO concentration. (A) Time-course of the chemiluminescence
emission intensity of 20 µM HNOCL-1 and 50 µM Angeli's salt. (B) Conversion from relative
emission intensity to [1] using the calibration curve in Figure 3-16, B. (C) Time-course of the
derivative determined from the plot in Figure 3-17, B. (D) HNO concentration measured using
equation 1 (black data points) and simulated by numerically solving equation 20 (red trace).
3.4.8 Selectivity tests for HNOCL-1
Selectivity for HNOCL-1 was measured by monitoring the time-dependent chemiluminescent
emission at 525 nm with an F-7000 fluorescence spectrophotometer (Hitachi, Tokyo, Japan). All
assays were performed in 20 mM HEPES buffered to pH 7.4, except for HO•, which was performed
in 20 mM PBS buffered to pH 7.4. All analytes were tested with final concentration of 200 μM,
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with the exception of glutathione (2 mM) and L-cysteine (1 mM).
HNO (200 µM): Angeli’s salt (Na2N2O3) was used to generate HNO. The stock solution was made
by dissolving Angeli’s salt in 0.01 M NaOH solution immediately prior to use. The concentration
of this alkaline stock solution of Angeli's salt was measured by UV/Vis is using e = 6100 M–1 cm–
1

at 237 nm. 13.6 μL of a 14.7 mM stock solution of Angeli's salt in 0.01 M NaOH was added to a

986 μL solution of 20 μM HNOCL-1 (from 4 µL of a 5 mM stock solution) in HEPES buffer.
ONOO– (200 µM): 7 μL of 28.5 mM ONOO– was added to a solution of 989 μL HEPES buffer
and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.
NO2– (200 µM): 4 μL of 50 mM NaNO2 in DI-H2O was added to a solution of 992 μL HEPES
buffer and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.
L-Cysteine (1 mM): 10 µL of 100 mM L-cysteine and 4 µL of 5 mM HNOCL-1 (20 µM final
concentration) in DMSO were added to 986 µL HEPES buffer.
GSNO (200 µM): 4 μL of 50 mM GSNO in DI-H2O was added to a solution of 992 μL HEPES
buffer and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.
GSH (2 mM): 20 μL of 100 mM GSH in DI-H2O was added to a solution of 976 μL HEPES buffer
and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.
H2O2 (200 µM): 4 μL of 50 mM H2O2 in DI-H2O was added to a solution of 992 μL HEPES buffer
and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.
t

BuOOH (200 µM): 4 μL of 50 mM tBuOOH in DI-H2O was added to a solution of 992 μL HEPES

buffer and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.

88

O2•– (200 µM): 280 µL of 5 mM HNOCL-1 stock solution (20 µM final concentration) in DMSO
was added to 70 mL HEPES buffer, later 1.0 mg KO2 (200 µM final concentration) was added to
the mixture.
Na2S (200 µM): 4 μL of 50 mM Na2S in DI-H2O was added to a solution of 992 μL HEPES buffer
and 4 μL of 5 mM HNOCL-1 in DMSO (20 µM final concentration).
HO• (200 µM): 4 µL of 5 mM HNOCL-1 stock solution was added to 988 µL 20 mM PBS buffer
(pH = 7.4). Later 4 µL 50 mM Fe(ClO4)2 and 4 µL of 50 mM H2O2 were added to the mixture.
NO (200 µM): DEA NONOate was used to generate NO. It was stored at –20 °C and dissolved in
0.01 M NaOH solution immediately prior to use. The concentration of this alkaline stock solution
of DEA NONOate was measured by UV/Vis using e = 6500 M–1 cm–1 at 250 nm. 2.51 μL of 79.7
mM DEA NONOate in 0.01 M NaOH solution was added to a 993 μL solution of 20 μM HNOCL1 in HEPES buffer.
OCl– (200 μM): 4 μL of 50 mM NaOCl in DI-H2O was added to a solution of 992 μL HEPES and
4 μL of 5 mM HNOCL-1 in DMSO (20 µM final concentration).
Blank: 4 µL of 5 mM HNOCL-1 stock solution was added to 996 µL HEPES.

3.4.9 Cell culture and biological studies
Macrophages (RAW 264.7) were purchased from Sigma-Aldrich and cultured in high glucose
Dulbecco's Modified Eagle Media (DMEM) supplemented with 10% Fetal Bovine Serum (FBS)
and 1% antibiotics (penicillin/streptomycin, 100 U/mL). Human lung adenocarcinoma epithelial
cells (A549) cells were purchased from ATCC and cultured in Ham’s F-12K (Kaighn’s) Medium
supplemented with 10% Fetal Bovine Serum (FBS) and 1% antibiotics (penicillin/streptomycin,
100 U/mL). Cells were maintained in a humidified incubator at 37 °C with 5% CO2. One or two
days before the experiment, cells were passaged and plated on Costar® 12-well plates by adding
150K–200K of cells per well, filling each well up to 1 mL of media. Chemiluminescent responses
were measured using a Cytation 5 BioTek plate reader (Winooski, VT). Fluorescent imaging was
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conducted using an EVOS-fl fluorescent microscope (Advanced Microscopy Group) equipped
with a GFP filter cube.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Human lung
adenocarcinoma epithelial cells (A549) were purchased from ATCC and were seeded in a 96-well
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crystals. Absorbance was measured at 570 nm in a Cytation 5 BioTek plate reader and cell viability
was expressed as a percent of the control.
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Figure 3- 18. A549 cells were incubated with 0–100 µM HNOCL-1 for 16 hours and then viability
was evaluated using the MTT assay. Error bars are ± S.D. from n = 3 replicates.

Detection of Angeli’s salt-generated HNO in living cells. Human lung adenocarcinoma
epithelial cells (A549) or RAW 264.7 macrophages were seeded in a 12-well plate to a total
volume of 1 mL/well. Before imaging, the medium was removed upon 90%–95% confluency and
the cells were washed with 1 mL PBS. Each well was fill with 996 µL FluoroBrite DMEM or F12K media. Later, 4 µL of 5 mM HNOCL-1 in DMSO (20 µM final concentration) was added to

-10-18, and 5-12-18

each well and incubated for 30 minutes. After incubation, the medium was removed and the cells
were washed with 2 x 1 mL PBS. Different volumes of 73.3 mM Angeli’s salt in 0.01 M NaOH
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(0 µL, 2.73 µL, 6.8 µL and 13.6 µL) were added to each well. The luminescence was measured
with a Cytation 5 BioTek plate reader using the luminescence detection mode directly after the
addition of Angeli’s Salt, end point read type. The temperature was set at 37 °C and the CO2 was
set at 5%. Each experiment consisted of three technical replicates for each condition, and each
experiment was repeated with three biological replicates on three separate days. The reported
integrated chemiluminescence intensity values are the average of a total of nine wells across three
1000
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Figure 3- 19. (A) Time course of chemiluminescent emission and (B) integrated emission intensity
of RAW 264.7 macrophages incubated with 20 µM HNOCL-1 for 30 minutes, washed and then
treated with 0, 200, 500, and 1000 µM AS. Error bars are ± S.D from n = 9 wells across 3 biological
replicates.
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biological replicates.

epithelial cells (A549) were seeded in a 12-well plate to a total volume of 1 mL/well. Before
imaging, the media was removed upon 90%–95% confluency and the cells were washed with 1
mL PBS. Each well was filled
with
996 µL F-12K media. 4 µL of 5 mM HNOCL-1 stock solution
0
600 1200 1800 2400
Time / min

in DMSO was added to each well (20 µM final concentration of HNOCL-1) and incubated for 30
minutes. After incubation, the media was removed and the cells were washed with 2 x 1 mL PBS.
An aliquot of 4 µL of 50 mM Na2S in H2O was added to the appropriate wells. Next, aliquots of
50 mM N-acetyl-L-cysteine in H2O (2 mM final concentration) were added to the appropriate wells.
Finally, aliquots of a 203.8 mM DEA NONOate (1 mM final concentration) were added to the
appropriate wells. The luminescence was measured with a Cytation 5 BioTek plate reader using
the luminescence detection mode, end point read type (Figure 3-19, A). The temperature was set
at 37 °C under ambient atmosphere. The gain was set at 135 and the read height was set at 4.5 mm.
Control values are the average of 11 technical replicates from 4 biological replicates. Other

data from 2-12-18, 5-10-18, and 5-12-18
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experiments are the average of 5–6 technical replicates from 2 biological replicates. Significant
outliers (2 of 36 total data points) were excluded using a Grubb's Test for Outliers with p < 0.05.

Fluorescence Microscopy with XF2. For cellular imaging with XF2, cells were passaged every
3–4 days. One day before imaging, 6-well plates (Falcon) were seeded with 300,000–500,000 cells
per well. 6-well plates were incubated in 5% CO2 and 37 ºC overnight to reach ca. 80% confluence.
A final concentration of 10 μM XF2 was used for all experiments. Angeli’s salt was used as a
nitroxyl donor and the stock solution concentration was determined by UV/Vis prior to use.
Fluorescence imaging was performed in PBS or final F12K media as described above using an
EVOS-fl inverted fluorescence microscope (Advanced Microscopy Group, Bothell, WA) equipped
with a GFP filter cube (470/22 nm Excitation; 510/42 nm Emission) and 40x objective. Images
were analyzed in ImageJ by converting the raw image into an 8-bit image, adjusting the threshold
and selecting cells using the standard ImageJ Huang52 or Otsu53 algorithms, and measuring the
mean pixel intensity in the selected areas. All quantification is from 3 fields/well with 3 biological
replicates performed on different days (n = 9). The mean value for each set of conditions across
all biological replicates was divided by the mean value of the controls across all biological
replicates for normalization (n = 9). All images within each experiment were analyzed identically.
Evaluation of background signal. Human lung adenocarcinoma epithelial cells (A549) were
seeded in a 12-well plate to a total volume of 1 mL/well. Before imaging, the medium was removed
upon 60%–80% confluency and the cells were washed with 1 mL PBS. Three wells of cells were
treated with 4 µL of 5 mM HNOCL-1 in DMSO (20 µM final concentration) and incubated for
30 minutes and compared to three wells of cells not treated with HNOCL-1. After incubation, the
medium was removed and the cells were washed with 2 x 1 mL PBS. The luminescence was
measured with a Cytation 5 BioTek plate reader using the luminescence detection mode, end point
read type. The temperature was set at 37 °C under ambient atmosphere. The gain was set at 135
and the read height was set at 4.5 mm. Data are from 3 technical replicates.
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Figure 3- 20. Evaluation of background. Time-course of the chemiluminescence emission
intensity of A549 cells incubated in the presence (red trace) or absence (blue trace) of 20 μM
HNOCL-1. Error bars are ± S.D. from n = 3 wells of cells.

Figure 3- 21. Fluorescence microscopy images of HNO detection in live A549 cells using XF2.
A549 cells were incubated with 10 μM XF2 for 30 min in F12K media at 37 °C and washed with
PBS before adding (A) 0 µM, (B) 50 µM, or (C) 200 µM Angeli's salt in F12K media for the final
30 min. (D)–(E) Brightfield images of the field of cells in (A)–(C). (G) Quantification of the mean
pixel intensity of cells of replicate experiments (n = 9; 3 biological replicates with 3 fields of cells
in each replicate). (H) Comparison of the normalized fold turn-on of XF2 and HNOCL-1 upon
treating cells with 200 µM Angeli's salt (dark grey bars) versus control (light grey bars). Statistical
analysis was performed using a two-tailed Student's t-test. ** indicates a p-value < 0.001 with
respect to the control. Error bars are ± S.D. from n = 9 fields across 3 biological replicates. Error
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bars for HNOCL-1 are ± S.D. from n = 9 wells across 3 biological replicates. Scale bars represent
50 µm.
Cell permeability of HNOCL-1. Human lung adenocarcinoma epithelial cells (A549) were
seeded in a 12-well plate to a total volume of 1 mL/well. Before imaging, the medium was removed
upon 60%–80% confluency and the cells were washed with 1 mL PBS. Each well was filled with
996 µL F-12K media. Later, 4 µL of 5 mM HNOCL-1 in DMSO (20 µM final concentration) was
added to three wells and incubated for 30 minutes. After incubation, the medium was removed and
the cells were washed with 2 x 1 mL PBS. Angeli's salt (final concentration 200 µM) was added
to the wells containing HNOCL-1 and the cells were incubated for 2 hours. Imaging was
performed using an EVOS-fl fluorescence microscope containing a GFP filter cube (470/22 nm
Excitation; 510/42 nm Emission), 40x objective, with the light intensity set to 70% and the
exposure time set to 500 ms. The fluorescence emission from cells treated with probe was
compared with the autofluorescence of untreated cells. The brightness and contrast of fluorescence
images were identically adjusted with a minimum pixel intensity of 27 and a maximum pixel
intensity of 91.

Figure 3- 22. Cell permeability. Fluorescence microscopy images of (A) autofluorescence from
untreated A549 and (B) A549 cells incubated with 20 µM HNOCL-1 for 30 minutes, washed and
treated with 200 µM Angeli's salt. (C)–(D) Brightfield images of the fields shown in (A)–(B).
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Imaging in Chicken Heart Tissue. Fresh chicken (gallus gallus domesticus) hearts (purchased
from the Good Fortune Supermarket, Richardson, TX) were stored at –4 ºC. Control hearts (Figure
3-8 A and Figure 3-12 A, top row) were injected with 20 µM HNOCL-1 in 20 mM PBS (pH 7.4)
containing ≤ 1% DMSO and 11.7 µL 0.01 M NaOH as a vehicle control. HNO-treated hearts
(Figure 3-8 B and Figure 3-12 A, bottom row) were injected with 20 µM HNOCL-1 in 20 mM
PBS (pH 7.4) containing ≤ 1% DMSO and 11.7 µL of 85.5 mM Angeli's salt in 0.01 M NaOH for
a final concentration of 1 mM Angeli's salt. Images were acquired every 30 seconds using a Caliper
Xenogen IVIS Spectrum® (PerkinElmer, Santa Clara, CA) with a 5 second exposure time, large
binning, f-stop set to 1, blocked excitation, open emission, FOV set to C, and height set to 1.5.
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Figure 3- 23. Imaging in heart tissue. (A) Images of chicken hearts injected with 20 µM HNOCL1 and (A) vehicle control or (B) 1 mM Angeli's salt in 20 mM PBS (pH 7.4) containing ≤ 1%
DMSO (n = 3 hearts). (B) Time course of the total flux from ROIs selected around the entire hearts
for the control experiment (blue trace) and after injection with Angeli's salt (red trace). Statistical
analysis was performed using a two-tailed Student's t-test. For data points at time 0 and 0.5 min, p
< 0.01 with respect to the control. For data points from 1 min to 9 min, p < 0.05 with respect to
1000
the control. Error bars are ± S.E. from
n = 3 hearts.
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Imaging in Living Mice. The UT Southwestern Institutional Animal Care and Use Committee
approved these investigations under Animal Protocol Number (APN #2017-102329). Mice were
anesthetized and maintained using inhalation
of 1.6%
isoflurane.
Anesthetized BALB/c nude were
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injected in the intraperitoneal (IP) cavity with 40 µM HNOCL-1 and either a vehicle control (0.01
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M NaOH) or 1 mM Angeli's salt in 20 mM PBS (pH 7.4), containing 5% DMSO. Images were
acquired every 30 seconds using a Caliper Xenogen IVIS Spectrum® (PerkinElmer, Santa Clara,
CA) with auto exposure, medium binning, f-stop set to 1, blocked excitation, open emission, FOV
set to C, and height set to 1.5. Movie S1 was constructed from the frames shown in Figure 3-25
(30 second intervals) and shows a time-lapse of the chemiluminescence imaging of the mouse

Total flux / p s–1 x 105

injected with Angeli's salt.
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Figure 3- 24. Quantification of live animal imaging experiments. Total photon flux from nude
BALB-C mice injected with 40 µM HNOCL-1 and vehicle control (blue trace, n = 1 mouse) or 1
mM Angeli's salt in 20 mM PBS (pH 7.4) containing 5% DMSO (red trace, n = 1 mouse).
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Figure 3- 25. Frames of the Movie S1. The frames are from images collected at 30 second
intervals for a total time-lapse of 30 minutes.
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APPENDIX
Synthesis of porcine liver esterase probe

19

Scheme A-1. Synthesis Procedures for Chemilum-CM2.
OMe Cl
O

O
O
CN

19

(3-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chloro-6-((E)-2cyanovinyl)phenoxy)methyl 1-methylcyclopropane-1-carboxylate (19). Chloromethyl 1methylcyclopropanecarboxyate1 (116 mg, 0.783 mmol, 1.5 equiv) was added to the dry, N2 filled
flask, then dissolved with 2.1 mL anhydrous acetone. NaI (129 mg, 0.858 mmol, 1.7 equiv) was
added to the solvent and the mixture was stirred for 24 hours at ambient temperature. The reaction
was concentrated under reduced pressure. Purification by chromatography (CH2Cl2) yielded a pale

(1)

Tian, L., Yang, Y., Wysocki, L. M., Arnold, A. C., Hu, A., Ravichandran, B., Sternson, S.
M., Looger, L. L., Lavis, L. D. Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 4756–4761.
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yellow

oil.

(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-3-chloro-2-

hydroxyphenyl)acrylonitrile 2 , 3 (184 mg, 0.518 mmol, 1.0 equiv) was dissolved with 2.0 mL
anhydrous DMF in an dry, N2 filled flask and anhydrous N,N-diisopropylethylamine (DIPEA, 0.19
mL, 1.1 mmol, 2.1 equiv) was added to the solvent. The pale yellow oil was dissolved with 3.0
mL anhydrous DMF and added to the flask. The reaction mixture was stirred for 21 h at ambient
temperature. The reaction was concentrated under reduced pressure. Purification by column
chromatography (1:20 EtOAc/Hexane) yielded 19 as a white solid (107 mg, 44%). 1H NMR (500
MHz, CDCl3) d 7.63 (d, 1H, J = 16.6 Hz), 7.36 (d, 1H, J = 8.1 Hz), 7.11 (d, 1H, J = 8.1 Hz), 5.95
(d, 1H, J = 16.6 Hz), 5.70 (m, 2H), 3.29 (s, 1H), 3.25 (s, 1H), 2.04 (s, 1H), 1.94–1.63 (m, 12H),
1.28 (s, 3H), 1.23 (m, 2H), 0.77 (m, 2H); 13C NMR(500 MHz, CDCl3) d 175.07, 152.02, 144.76,
139.33, 139.04, 133.30, 129.21, 128.62, 128.54, 123.91, 117.83, 98.59, 89.32, 57.44, 39.19, 39.03,
38.61, 38.56, 36.96, 32.91, 31.59, 29.73, 28.29, 28.11, 19.10, 18.54, 17.60; HRMS calcd for
C27H30ClNO4 (M+Na+) 490.1756, found 490.1755.

O

OO

Cl
O

O
O
CN

Chemilum-CM2
(2-chloro-6-((E)-2-cyanovinyl)-3-((1r,3r,5r,7r)-4'-methoxyspiro[adamantane-2,3'-[1,2]dioxetan]4'-yl)phenoxy)methyl 1-methylcyclopropane-1-carboxylate (Chemilum-CM2). Enol ether 19
(107 mg, 0.230 mmol, 1.0 equiv) was dissolved with 5 mL THF at 0 °C in a two-neck flask and
rose bengal (12.4 mg, 0.0122 mmol, 0.050 equiv) was added to the solvent. O2 was bubbled
through the solvent when illuminated with a 120W light bulb (Home Depot, Dallas, TX). The
reaction was monitored by TLC. After 3 h 15 min, the mixture was concentrated under reduced
pressure. Purification by column chromatography (1:20 EtOAc/Hexane) and yield ChemilumCM2 as a white solid (76.9 mg, 67%). 1H NMR (500 MHz, CDCl3) d 7.97 (d, 1H, J = 8.6 Hz),
7.66 (d, 1H, J = 16.7 Hz), 7.52 (d, 1H, J = 8.6 Hz), 6.03 (d, 1H, J = 17.2 Hz), 5.67 (dd, 2H), 3.21(s,

(2)
(3)

Cao, J., An, W. W., Reeves, A. G., Lippert, A. R. Chem. Sci., 2018, 9, 2552–2558.
Green, O., Eilon, T., Hananya, N., Gutkin, S., Bauer, CR., Shabat, D. ACS Central Sci., 2017,
4, 349–358.
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3H), 3.01(s, 1H), 1.96 (s, 1H), 1.85-1.58(m, 12H), 1.28 (s, 3H), 1.23 (m, 2H), 0.79 (m, 2H); 13C
NMR(500 MHz, CDCl3) d 175.11, 152.70, 144.42, 136.53, 130.51, 129.80, 127.19, 124.13, 117.63,
111.63, 99.99, 96.48, 89.32, 49.87, 36.57, 33.99, 33.66, 32.67, 32.24, 31.62, 31.58, 29.82, 26.17,
25.83, 19.18, 18.59, 17.74; HRMS calcd for C27H30ClNO6(M+Na+) 522.1654, found 522.1654.
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Cell Culture Protocol
Media/reagent for cell lines:
Currently, the cell lines being used in the lab are A549 lung cancer epithelium and RAW 264.7
macrophage cells.
For A549: Complete F12K medium is typically used.
For Macrophages: Complete DMEM medium is used.
Preparation of complete medium: 10% FBS and 1% antibiotic in completed media.
Under the hood, open a new 500 mL bottle of the media. Using a 55 mL pipette, remove 55 mL of
media into a falcon tube and keep aside. Add 50 mL FBS (filtered if possible, but not totally
necessary) and 5 mL of pen/strep antibiotic to the 455 mL medium. Pipette up and down. Label as
Opened and complete, with date and initials and store in the refrigerator. FBS is stored in the -80
ºC freezer (prepare 4 aliquots of 50 mL in each Falcon tube before storing).
Thawing of vials and seeding:
1.

New vials of cells can be ordered through the ATCC website, paying careful attention to
cell line/strain description.

2.

If thawing a vial that is stored in our liquid nitrogen dewar, keep track of vials used. Make
sure to label the removed cells on the Liquid Nitrogen Storage Chart.

3.

Thawing: Keep the appropriate media warmed in the water bath to 37 ºC and sterilize the
hood with UV light for at least 10 mins. With a pipette, pour about 10 mL of warmed
completed media into a 15 mL or 50 mL falcon tube. The vial of cells is carefully dipped
(not immersed) in water bath until just a tiny portion of the ice is remaining. Remove the
vial and wipe with ethanol.

4.

Open lid of vial slowly to release pressure and then transfer the contents into the media of
the falcon tube with the 1000 µL pipet.

5.

Centrifuge for 10 minutes at 1000 rpm.

6.

With a pipette, pour 20 mL of warmed completed media into a T75 flask (or 3 mL to a T25
flask). Taking the falcon tube out, aspirate liquid supernatant and disperse the pellet in
around 1 mL of fresh completed media. Add all the cells to the T75 flask and distribute
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cells with gently rocking of the flask. Label the flask with date, passage number, cell line
and initials and place in the incubator.
7.

On the next day, check the cells and remove the media with the aspirator. Add 20 mL new
complete media to the T75 flask. The purpose of this step is to remove the dead cells that
didn’t survived the freezing and thaw cycle.

Cell Passaging:
A549
1. Keep the F12K complete media, PBS and 0.25 % trypsin in the water bath about 30 mins
to warm up to 37 ºC. Turn on the UV of the hood and leave between 10 – 30 mins.
2. When the bottles are warm, wipe out the water, spray with alcohol and keep ready in the
hood, remove the flask from the incubator and aspirate the media. Wash the cells once with
about 10 mL PBS. Aspirate the PBS.
3. Add around 2 mL of trypsin to the T75 flask (1 mL for T25). Move the plate around a bit
to make sure all the cells are coated with trypsin. Keep the flask in the incubator for 8 to
10 mins. Trypsin breaks the bonding between the cell surface and the bottom of the flask
so that cells will detach and float.
4. Add between 10 mL of media to the flask and then transfer all the contents to a falcon tube.
Centrifuge 10 mins at 1000 rpm.
5. Aspirate the supernatant. Thoroughly distribute the cells in around 1 mL of media with up
and down motions of the pipette.
6. In a T75, pipette in about 20 mL of completed F12K. Depending on how many cells you
need, transfer about 150 µL of the cell cocktail to the flask. Distribute thoroughly with
gentle rocking of the flask. Label with date, passage number and generation, date and your
initial and put back to the incubator.

Macrophage:
1. Keep the DMEM complete media, PBS and 0.25 % trypsin in the water bath about 30 mins
to warm up to 37 ºC. Turn on the UV of the hood and leave between 10 – 30 mins.
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2. When the bottles are warm, wipe out the water, spray with alcohol and keep ready in the
hood, along with a cell scraper, remove the flask from the incubator and aspirate the media.
The cells are washed once with about 10 mL PBS. Aspirate the PBS.
3. Add around 1 mL of 0.25 % trypsin to the T25 flask (The amount of trypsin is depending
on the size of the T flask). Using the cell scraper, gently but quickly scrape all the cells off
the bottom of the flask. Do not allow the cells to be exposed too long to trypsin, since cells
become sticky.
4. Add between 10 mL of completed DMEM media to the flask and then transfer all of the
contents to a falcon tube. Centrifuge 10 mins at 1000 rpm.
5. Aspirate the supernatant. Thoroughly distribute the cells in around 1 mL of completed
DMEM media with up and down motions of the pipette.
6. In a T75, pipette in 20 mL of DMEM. Then depending on how many cells you need,
transfer about 150 µL of the cell cocktail to the flask. Label with date, passage number and
generation, date and your initial and put back to the incubator.

Cell Freezing:
1. Freezing of cells should be done after about 2 to 3 passages from a fresh thawed vial. Do
not allow for more passages to be done before freezing a batch of cells. It is recommended
that after thawing of a vial, the cells need to grow enough to make enough vials.
2. Make sure cell confluency is around 80–90% but not overgrown.
3. Cell freezing media needs to be prepared ahead of time. It is 10% cell-culture grade DMSO
in complete media.
4. Warm complete media, PBS, trypsin and cell freezing media and make sure hood has been
UV treated. Follow all the passaging steps for your cells line up to the pellet formation.
5. Aspirate the media and keep the pellet. From a sufficiently confluent flask you can make
around 10 vials of cells. Prepare 10 mL cell freezing media. Add 1 mL of cell freezing
media to the pellet first to disperse the cells thoroughly. Later add the rest of the freezing
media to the falcon tube. It is better to add 1ml first, then add the rest and mix.
6. The cryopreservation vials are used to freeze cells. Add 1 mL of the cell cocktail into as
many vials as possible with pipet. Close the vials tightly, label them with cell type,
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generation and passage number, date and initials. Parafilm the lids of all the vials. Store
them in a Mr. Frosty freezing container containing ethanol and keep overnight in the –80
ºC freezer (Dr. Zoltowski’s lab). Three days later, transfer the vials to the liquid nitrogen
dewar, make a note of the date stored, location and number of vials on the Liquid Nitrogen
Storage Chart.

Incubator and water bath water maintenance (Monthly)
The incubator needs to be at 37 ºC, 5% CO2 and water filled on the bottom to maintain
humidity and temperature. The water to needs be autoclaved before filling and treated with a
disinfectant (aquaguard from Sigma or Conflikt from VWR) about once a month. 2% of
disinfectant in autoclaved water should be enough. Conflikt is also used to wipe down the incubator
every semester on group clean-up day (instead of alcohol). The water in the water bath needs to
be changed and treated in the same way (once a semester on group clean-up day).
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